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Candida albicans is a polymorphic fungus that causes a range of disease in
humans, from mucosal infections to systemic disease. Its ability to cause disease is
linked to conversion between yeast and filamentous forms of growth, and the first
quorum-sensing molecule discovered in an eukaryote, farnesol, blocks this transition. In
C. albicans, farnesol also kills mating-competent opaque cells, inhibits biofilm formation,
protects the cells from oxidative stress, and can be a virulence factor or protective agent
in disseminated and mucosal mouse models of infection, respectively. While much
emphasis has been placed on determining its effect on C. albicans morphology, the
molecular response to farnesol is not completely understood. The overall theme for this
dissertation was to better understand the C. albicans molecular response to farnesol under
quorum sensing conditions. Due to the duplicitous nature of the farnesol response in C.
albicans, i.e., its ability to kill cells or simply alter morphology, we clearly defined the
environmental conditions in which farnesol acts as a quorum sensing molecule or as a
toxic agent towards C. albicans. This clarification enabled a subsequent two-pronged
approach to study the molecular response to farnesol during morphological regulation. A
direct approach was used to investigate the role of a likely candidate, Tup1, a negative
regulator of hyphal development, in farnesol signaling. Secondly, a screening approach
was utilized to identify new farnesol resistant mutants that may participate in the farnesol

response. From the mutants identified, Czf1 (C. albicans zinc finger) was selected for
further characterization and was shown to play a vital role in the morphological response
to farnesol as well as farnesol tolerance. Overall, this study identified two new factors
involved in farnesol signaling, and highlights the power of farnesol as a tool with which
to unravel the complex signaling networks present in C. albicans.
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CHAPTER 1
INTRODUCTION

Reference:
Langford, M.L., Atkin, A.L., and Nickerson, K.W. (2009) Cellular Interactions of
Farnesol, a Quorum Sensing Molecule Produced by Candida albicans. Future Microbiol.
4: 1353-62.
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INTRODUCTION
The discovery of E,E-farnesol as a quorum sensing molecule in Candida albicans
(Hornby et al., 2001) demonstrated the existence of quorum sensing in a eukaryotic
organism, a process once thought to be confined to bacteria. The earlier work on the
discovery and characterization of farnesol was reviewed by Nickerson et al (Nickerson et
al., 2006). C. albicans is a polymorphic fungus that is capable of growing in yeast,
hyphal, pseudohyphal, opaque, and chlamydospore cell morphologies.

Farnesol is

capable of blocking the yeast to hyphal/pseudohyphal (filaments) switch (Hornby et al.,
2001), a conversion that is the focus of intense study in C. albicans because of its role in
virulence (Lo et al., 1997; Saville et al., 2003). Another quorum sensing molecule
(QSM) described in C. albicans is farnesoic acid (Oh et al., 2001). Farnesoic acid, like
farnesol, acts to block the yeast to filament transition (Oh et al., 2001), but it is far less
active than farnesol (Shchepin et al., 2003) and is produced by only one known strain of
C. albicans, 10231 (Hornby and Nickerson, 2004; Oh et al., 2001). Additional possible
quorum sensing molecules are reviewed by Kruppa (Kruppa, 2009). Farnesol also blocks
biofilm formation by C. albicans (Alem et al., 2006; Cao et al., 2005; Martins et al.,
2007; Ramage et al., 2002) in a manner consistent with its inhibition of the yeast to
filament conversion. The mating-competent form of C. albicans, opaque cells, can be
adversely affected by farnesol; in aerobic conditions the cells die by necrosis (Dumitru et
al., 2007) but remain unharmed in anaerobic conditions (Dumitru et al., 2004). Lastly,
the production of chlamydospores, a C. albicans cell morphology with unknown
function, is increased in the presence of very high (10 mM) levels of farnesol (Martin et
al., 2005). Given that it may affect all five C. albicans growth morphologies, it has
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become clear that farnesol plays an influential role in C. albicans physiology, and the
search is underway to elucidate the molecular mechanism(s) of these effects.
The Molecular Response to Farnesol in C. albicans
The first described function of farnesol was to block filamentation induced by a
variety of environmental signals (Hornby et al., 2001; Mosel et al., 2005), and several
factors involved in the filamentation process are known to play a role in the C. albicans
farnesol response. Ras1 of the cyclic AMP pathway, as discussed later, is a candidate for
direct inhibition by farnesol (Davis-Hanna et al., 2008). Repressors of filamentation,
Tup1 and Nrg1, also play critical roles in the farnesol response, as tup1Δ/tup1Δ and
nrg1Δ/nrg1Δ mutants are unable to respond to farnesol (Kebaara et al., 2008). The
presence of farnesol increases TUP1 expression and suppresses the haploinsufficient
phenotype of a TUP1/tup1Δ mutant (Kebaara et al., 2008). A two-component signal
transduction pathway histidine kinase, Chk1 (Kruppa et al., 2004), and mitogen activated
protein (MAP) kinase pathway components, Cph1 and Hst1 (Sato et al., 2004), may also
be involved in the response to farnesol, but Cph1 might play a downstream role since a
cph1Δ/cph1Δ mutant retains the ability to respond to farnesol (Davis-Hanna et al., 2008).
Regulators of filamentation are not the only genes involved in the farnesol response.
Microarray analyses have identified other categories of genes affected by farnesol
treatment such as heat shock genes, drug resistance genes, cyclin and cell proliferation
genes, histone genes, genes expressed at high cell density, phagocytosis response genes,
and adhesion genes (Cao et al., 2005; Cho et al., 2007; Enjalbert and Whiteway, 2005;
Uppuluri et al., 2007). With all of the different pathways and responses induced by
farnesol, it promotes the question: Does farnesol have one or more specific target(s) in
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the cell, or does it somehow elicit a more general and nonspecific response with
pleomorphic consequences?
Are there farnesol receptors or farnesol binding proteins? The morphological
response to farnesol in C. albicans appears to be very sensitive to minor changes in the
structure of farnesol, providing support for the specific target(s) model, rather than a
scenario involving general membrane disruption. For example, there are four isomers of
farnesol but only E,E-farnesol is capable of blocking filamentation in C. albicans
(Shchepin et al., 2003). This conclusion is based on a comparison between pure (96%)
E,E-farnesol and two commercial mixed isomers containing 56 and 36% E,E-farnesol.
These three farnesol preparations reduced germ tube formation (early stage filaments) to
50% at 1.2, 3.5, and 4.4 µM, respectively (Shchepin et al., 2003). Thus, there was
sufficient E,E-farnesol in the two samples with mixed isomers to account for all of their
QSM activities. Further, the 12-carbon backbone of farnesol appears to be critical for its
ability to block filamentation because altering the chain length generally results in
decreased filament inhibitory activity (Hogan et al., 2004; Kim et al., 2002; Shchepin et
al., 2003; Shchepin et al., 2005). Other farnesol analogs and related molecules from
other organisms, such as 3-oxo-C12-homoserine lactone and dodecanol, are capable of
blocking filamentation in C. albicans, suggesting some limited flexibility for the
inhibitory action of farnesol-related molecules (Davis-Hanna et al., 2008; Hogan et al.,
2004; Kim et al., 2002; Shchepin et al., 2003; Shchepin et al., 2005). One, but not the
sole explanation for these results is the presence of a farnesol receptor(s) or farnesol
binding protein(s) in C. albicans. Fluorescent farnesol (Shchepin et al., 2005) and a
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farnesol affinity column (Shchepin, 2006) were developed to help isolate farnesol binding
proteins, so far with limited success.
Farnesol and Ras1/cAMP Signaling
Ras1 and the adenylyl cyclase-cAMP-protein kinase A (PKA)-Efg1 pathway (Fig.
1) have been proposed as a potential direct target for farnesol inhibition (Davis-Hanna et
al., 2008). This idea is very reasonable and it is persuasive that farnesol was able to
reverse filamentation in the dominant active (CAI4-RaslG13V) mutant of C. albicans and
farnesol inhibition of filament formation was itself reversed by addition of dibutyrylcAMP (Davis-Hanna et al., 2008, discussed in more detail by Paula Sundstrom and
Deborah Hogan in this issue).

It may be important that Ras1 is one of the few

farnesylated proteins in C. albicans, and it has been estimated that the farnesylated,
membrane-bound form of Ras1 is ca. 100 X more effective in activating adenylyl cyclase
than is the cytoplasmic form (Kuroda et al., 1993). Thus, there are several ways by
which farnesol could inhibit the Ras1-cAMP-PKA-Efg1 pathway (Fig. 1). A partial list
includes: blocking the farnesylation of Ras1, see review by Hancock et al (Hancock,
2003), releasing farnesylated Ras1 from the membrane (Fig. 1A), binding directly to
Ras1 (Fig. 1B), and binding directly to a downstream protein such as adenylyl cyclase
(Fig. 1C). It is unlikely that farnesylated Ras1 has the farnesyl tail removed because it is
attached by a very stable thioether bond and, where measured, farnesylated Ras1 has a
long half life.
Having Ras1 as a direct target for farnesol can provide some unity for many of the
filamentation genes involved in the farnesol response since it is a common regulator for
the Hst7/Cph1 MAP kinase pathway and the cAMP pathway (Castilla et al., 1998; Feng
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et al., 1999; Leberer et al., 2001). While it is unknown what factors regulate Tup1/Nrg1
and Chk1, it is possible that they are also under the control of Ras1. A second possibility
for farnesol signaling is the presence of multiple farnesol targets, each affecting different
aspects of filamentation in response to different inducing stimuli, while a third possibility
is that farnesol interacts with the cell membrane in a very specific manner to induce a
pleiotropic signaling response in the rest of the cell. Notice that Figure 1 has been drawn
with both intracellular and extracellular farnesol. This was done to emphasize that
further research is warranted to determine the exact nature of the molecular response to
farnesol during yeast to filament inhibition. It is difficult to say whether farnesol acts
from the outside or the inside because it can cross the cytoplasmic membrane by
diffusion. On the one occasion when cellular localization was attempted (Navarathna et
al., 2005), the values for extracellular, intracellular, and membrane-associated farnesol
were 0.115, 0.009, and 0.106 mg/g dry weight of cells, respectively (Navarathna et al.,
2005). These values correspond to concentrations of ca. 4 µM extracellular (Nickerson et
al., 2006) and 13.5 µM intracellular, with the intracellular calculation based on a yeast
cytoplasmic volume of ca. 3 µl/mg dry weight. Similarly, the membrane-associated
farnesol would constitute 1-2% of the total extractable membrane lipids based on a value
of 8.5 mg extractable lipid/g dry weight (Hitchcock et al., 1986).
Possible Artifacts
We have found several artifacts associated with the cellular response to farnesol.
Caveats which must be considered include: 1) some auxotrophic mutants (his1Δ/his1Δ,
arg4Δ/arg4Δ) produce germ tubes faster than their wild type, prototrophic counterparts
and 2) as a consequence, when examining a mutant for its response to farnesol, it is
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always safer to run a time course with and without farnesol until 90-100% germ tube
formation has been achieved in the control lacking farnesol (our unpublished data). This
prevents a misinterpretation for lack of farnesol response rather than a faster rate of
filamentation. A third potential artifact is derived from farnesol’s lipophilic nature. We
previously pointed out how ca. 150x more farnesol was needed to block germ tube
formation in the presence of 10% serum than in its absence (Mosel et al., 2005). The
farnesol concentration would be effectively reduced because of the lipid binding capacity
of serum albumins. A similar trap could occur when farnesol’s action in blocking germ
tube formation or inhibiting growth is reversed by added diacylglycerol (DAG) or 1oleoyl–2-acetyl-sn-glycerol (OAG). Machida et al (Machida et al., 1999), Voziyan et al
(Voziyan et al., 1995) and Uppuluri et al (Uppuluri et al., 2007) attributed internal modes
of action, i.e. protein kinase C activation (Voziyan et al., 1995) or interference with
phosphatidylinositol signaling (Machida et al., 1999; Uppuluri et al., 2007), to this
DAG/OAG reversal. However, micelle forming detergents or lipids such as DAG and
OAG could incorporate the farnesol and effectively reduce its concentration. Thus, a
simple way of distinguishing between reversal by an external “micelle trap” versus a
more specific cytoplasmic mechanism is to find out whether equivalent amounts of
detergents such as Triton X-100 and NP40 also reverse farnesol’s action. This idea was
recently tested for farnesol’s growth inhibition of Candida parapsilosis. OAG and Triton
X-100 showed equivalent reversal of farnesol’s growth inhibition (T. Rossignol and G.
Butler, personal communication), and in this case, no conclusions could be drawn on
farnesol’s intracellular mode of action.
Farnesol Production by Candida Species
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Weber et al (Weber et al., 2008) recently compared the farnesol production levels
from 56 strains of eight Candida species. C. albicans had the highest production levels
(35 + 16 µM) compared to the other Candida species tested:

C. dubliniensis, C.

tropicalis, C. parapsilosis, C. guilliermondii, C. kefyr, C. krusei, and C. glabrata (Weber
et al., 2008). The closely related species C. dubliniensis produced 8.7 + 3.8 µM farnesol
while the remaining Candida species all produced < 1 µM farnesol. This value for C.
albicans (35 µM) is substantially higher than our best estimates (Nickerson et al., 2006)
of 2 to 4 µM farnesol at a yeast cell density of 108/ml, based on production of ~ 0.13 mg
farnesol per g dry weight of fungus (Hornby and Nickerson, 2004). Production levels for
two laboratory and four clinical isolates were tightly clustered from 0.11 to 0.14 mg per g
dry weight (Hornby and Nickerson, 2004) whereas the seven strains of C. albicans
studied by Weber et al (Weber et al., 2008) varied from 13 to 58 µM farnesol. This wide
variance (Weber et al., 2008) might be resolved by normalizing the data on a per g dry
weight basis. Also, despite the different analytical procedures employed, GC/MS by
Hornby and Nickerson (Hornby and Nickerson, 2004) and derivatization with 9-anthroyl
nitrile followed by HPLC by Weber et al (Weber et al., 2008), the estimates of 35 µM vs.
2-4 µM farnesol may be compatible. If the cell densities achieved following 24 hrs
growth in RPMI at 37°C (Weber et al., 2008) were ca. 109/ml, compared to only 108/ml
in GPP at 30°C (Hornby and Nickerson, 2004), then the two data sets would be in
remarkably close agreement.
Careful consideration must also be given to the growth medium when measuring
farnesol production levels. For example, the addition of 10% fetal calf serum (FCS)
lowered farnesol production ca. 18-fold (Weber et al., 2008) but the mechanism behind
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this reduction remains unclear.

The nonspecific lipid binding capability of serum

albumin was evident in the fact that 150-fold more farnesol was needed to block
filamentation than in its absence (Mosel et al., 2005). Similarly, industrial stratagems to
maximize farnesol production (Muramatsu et al., 2008, 2009) commonly used an external
lipid sink such as 5% soybean oil to shift the equilibrium toward production and
excretion of farnesol. Thus, 10% FCS should have increased farnesol production rather
than decreased it (Weber et al., 2008). Possibly the low levels of farnesol detected with
10% FCS used an extraction protocol which did not fully denature the lipid-binding
albumins. The importance of a nearby lipid sink will be revisited in our discussion on the
role of farnesol in pathogenicity.
Manipulating the sterol biosynthetic pathway in C. albicans and other fungi with
inhibitors such as fluconazole, terbinafine, SQAD, or zaragozic acid can result in
increased farnesol production levels (Hornby et al., 2003; Hornby and Nickerson, 2004),
and three genes have been identified in C. albicans thus far that regulate farnesol
production: DPP3, TUP1, and NRG1 (Kebaara et al., 2008; Navarathna et al., 2007a).
C. albicans Dpp3 is an ortholog of the S. cerevisiae phosphatase Dpp1 (Toke et al.,
1998), and it presumably acts as a phosphatase to convert farnesyl pyrophosphate to
farnesol (Navarathna et al., 2007a). Deletion of the C. albicans DPP3 gene results in
farnesol production levels that are six times lower than wild type and parental levels
(Navarathna et al., 2007a). Conversely, Tup1 and Nrg1 appear to play a negative role in
farnesol production; tup1Δ/tup1Δ and nrg1Δ/nrg1Δ mutant strains produce 17 and 19fold higher farnesol, respectively, than their parents, but it is unclear whether this is a
result of direct or indirect sterol biosynthesis regulation (Kebaara et al., 2008). Further
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research is required to fully understand the regulation of farnesol production in both C.
albicans and other Candida species.
Farnesol and Interspecies Communication
A developing branch of research has focused on the effects of farnesol signaling
on interspecies communication. A brief summary of the effects of farnesol on other
organisms is described in Table 1. Filament and biofilm development are each blocked
by farnesol in the closely related C. dubliniensis, similar to the C. albicans morphological
response to farnesol (Henriques et al., 2007; Jabra-Rizk et al., 2006b; Martins et al.,
2007). In contrast, C. parapsilosis, which normally produces very low levels of farnesol,
appears to respond in a different manner; farnesol reduces C. parapsilosis biofilm
formation independently from filament inhibition (Laffey and Butler, 2005; Rossignol et
al., 2007).

The use of physiologically relevant farnesol concentrations to avoid

unintended cytotoxic effects will determine whether farnesol blocks dimorphism and/or
biofilm formation in other Candida species. In other cell types, farnesol can be inhibitory
or toxic, often accompanied by elevated reactive oxygen species (ROS) production.
However, these reports encompass a huge range of farnesol concentrations, many of
which are above the ca. 1 mM solubility limit for farnesol, increasing the likelihood that
the responses observed are both specific and non-specific, or detergent-like.
Given that the production of extracellular signaling molecules is certainly not
unique to C. albicans, there has also been some recent work describing the converse
situation in which the response of C. albicans to bacterial signaling molecules is
examined (Table 2). It is important to distinguish between general growth inhibition (an
antifungal antibiotic) and specific inhibition of one type of growth, e.g. a QSM blocking
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the yeast to filament transition in C. albicans. For instance (Table 2), while Burkholderia
diffusible signal factor (BDSF) at a 5 µM concentration inhibited 70% of germ tube
formation for C. albicans cells, that same concentration also strongly inhibited growth
(Boon et al., 2008). It is intriguing how a similar molecule produced by Xanthomonas
campestris, diffusible signal factor (DSF), can inhibit filamentation without any growth
inhibition (Boon et al., 2008; Wang et al., 2004), even though the two molecules differ
by only one methyl group. Molecules that are not inhibitory for the general growth of C.
albicans, yet induce a signaling response are legitimate candidates for cross-kingdom
signaling molecules (Table 2).
An interesting consideration to make when evaluating the variety of responses to
QSMs such as farnesol in different organisms is the likelihood of the cells to interact with
one another during the commensal state versus during an infection. Similarly, one must
also consider the location of the interaction within the host, as farnesol production by C.
albicans results in different host responses depending on the site of infection. For
instance, it is likely important for C. albicans commensal life style in the gastrointestinal
tract (Kumamoto and Vinces, 2005b) that farnesol production is turned off during
anaerobic growth (Dumitru et al., 2004). Lastly, farnesol must be used carefully and at
the appropriate physiologically relevant concentrations in order to avoid artifactual
observations, such as unintended cytotoxic effects.
Farnesol-Mediated Cell Death in C. albicans
With regard to the possibility of farnesol-mediated cell death, the literature has
conflicting reports on the appropriate levels of farnesol with which to treat C. albicans.
Several groups have used 150-250 µM farnesol with no apparent cell death (Davis-Hanna
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et al., 2008; Henriques et al., 2007; Hogan et al., 2004; Kruppa et al., 2004); one study
by Jabra-Rizk et al (Jabra-Rizk et al., 2006b) concluded the minimum inhibitory
concentration (MIC) for C. albicans was >250 µM while another study concluded that 40
µM farnesol induced cell death (Shirtliff et al., 2009). Conflicts have also emerged
regarding the concentration of farnesol needed to block filamentation in C. albicans, with
effective concentration reports ranging from 4 µM (Mosel et al., 2005), up to 250 µM
(Kruppa et al., 2004). Another important finding was that of Davis-Hanna et al (DavisHanna et al., 2008) who noted that higher concentrations of farnesol were required to
block filamentation in plastic microtiter plates compared to borosilicate glass tubes or
flasks, suggesting a possible farnesol adsorption effect by plastic that might lower the
effective concentration of farnesol. Our summary view is that the appropriate level of
farnesol to use for filament inhibition is ≤ 50 µM farnesol when using glassware; this
corresponds to physiologically relevant concentrations of farnesol produced by
stationary-phase C. albicans cultures (Weber et al., 2008). While the plastic versus
glassware variable may explain some discrepancies in the literature, additional variables
need to be considered when evaluating farnesol-mediated cell death in C. albicans.
Farnesol is clearly a bioactive molecule. With the caveat that inappropriately high
concentrations were often used, the recurrent theme in Table 1 is that farnesol is
inhibitory or lethal to a great many other cell types. Thus, a fundamental question is how
C. albicans has evolved to withstand the farnesol which it produces in great abundance.
This question is exactly analogous to an antibiotic producing strain being resistant to that
antibiotic. A corollary to this idea is that reports of farnesol mediated cell death be
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viewed as circumstances where C. albicans has let down its guard, i.e. the molecular
defense mechanisms are regulable rather than constant or intrinsic.
Farnesol has been reported to cause growth defects (Uppuluri et al., 2007),
necrosis (Dumitru et al., 2007) and apoptosis (Shirtliff et al., 2009) in C. albicans,
although the precise concentrations required are somewhat unclear, because different
conditions were used to grow the cells and different methods were used to assess cell
damage. Work is underway in our laboratories to investigate farnesol tolerance by C.
albicans, taking into account many environmental variables, in an effort to unify and
validate existing data in the literature (Langford et al, data not shown). Our conclusions
so far are that four factors are significant. First, only white cells of C. albicans are
resistant. Dumitru et al (Dumitru et al., 2007) observed that the opaque cells were very
sensitive to farnesol, being lysed rapidly by ≥ 40 µM. Following this line of thinking, in
a saturated aerobically grown culture of predominantly white cells, the farnesol levels
could possibly reach levels high enough to kill opaque cells. Second, farnesol resistance
is somewhat energy dependent. The farnesol-induced death and apoptosis reported by
Shirtliff et al (Shirtliff et al., 2009) was for cells which had been stored for 24h in PBS
buffer with no exogenous energy sources. Third, as was first pointed out by Uppuluri et
al (Uppuluri et al., 2007), the starting growth phase of the inoculum is critical. At 25°C,
C. albicans log-phase cells were considerably more sensitive to growth inhibition by
farnesol than were stationary-phase cells. Stationary-phase inocula maintained similar
growth rates and viability with 0-100 µM farnesol, while log-phase cells grew
considerably slower with 40 µM farnesol and viability was only 18% with 100 µM
farnesol added (Uppuluri et al., 2007).

Fourth, ROS are generated during farnesol
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treatment of both white and opaque cells, and evidence supports mitochondrial
perturbation when cytotoxic levels of farnesol are present (Dumitru et al., 2007; Shirtliff
et al., 2009; Uppuluri et al., 2007). The importance of ROS is also implicit in the
findings of Dumitru et al (Dumitru et al., 2007); under anaerobic conditions C. albicans
tolerated mM levels of farnesol.

Careful use of physiologically relevant farnesol

concentrations combined with clear indications of the previously mentioned variables
will hopefully prevent future confusion on this issue.
Is farnesol-mediated death in C. albicans induced in a specific or non-specific
manner? Evidence exists supporting both models. Ras1/cyclic AMP signaling again
becomes relevant as it is known that an activated Ras-cAMP-PKA pathway and cAMPstimulatory drugs promoted apoptotic cell death in C. albicans (Phillips et al., 2006).
However, the connection of farnesol to apoptosis (Shirtliff et al., 2009) is less clear.
Based on the findings of Phillips et al (Phillips et al., 2006), one would expect farnesol to
lessen apoptosis rather than to promote it. Additionally, the lysis of opaque cells by
farnesol was not apoptotic (Dumitru et al., 2007). Using the same procedures as had
been used for showing apoptosis in A. nidulans (Semighini et al., 2006), including the
definitive Annexin V test (Semighini et al., 2006), we were unable to demonstrate
apoptosis in farnesol lysed opaque cells (Dumitru and Nickerson, unpublished data).
Since farnesol is lipophilic, it has the ability to disrupt cell membranes, and this supports
the nonspecific-mediated killing model.

Understanding how farnesol regulates C.

albicans growth morphologies, growth rates, and even cell death, may be essential
components for understanding the role of farnesol in the host.
The Role of Farnesol In Vivo
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Our final topic is the role of farnesol during infection. At the time of its discovery
as a QSM, two ideas were put forward regarding its in vivo importance (Hornby et al.,
2001). One was that, due to its ability to block the yeast to filament transition, farnesol
treatment would act as a therapeutic in a mouse model of infection. The other was that
farnesol would act as a virulence factor. Research on the topic has shown that the role of
farnesol in vivo is not so simplistic.

Navarathna et al (Navarathna et al., 2005;

Navarathna et al., 2007a) showed that farnesol acts as a virulence factor in the mouse tail
vein injection assay, leading to the question of just how much farnesol is produced by C.
albicans in the mouse. A definitive answer to this question will be difficult. The in vitro
production estimates were for cells grown in glass flasks whereas in vivo production
would be for cells growing in close proximity to mouse membranes of many types which
could easily act as external lipid sinks, thus enhancing farnesol production.
C. albicans is capable of evading part of the host immune system by escaping
from macrophages through the production of filaments (Ghosh et al., 2009; Lorenz et al.,
2004). While external farnesol reduces the viability of macrophages in vitro (Abe et al.,
2009), the interesting question remains whether farnesol levels naturally produced by C.
albicans are high enough to affect macrophage function/viability and thus enable fungal
survival and escape from the macrophage. Does farnesol production in the
phagolysosome contribute to escape from the macrophage? Experiments which add
exogenous farnesol to the macrophage cannot answer this question. Also, an unfortunate
obstacle for answering this question directly with the dpp3Δ/dpp3Δ mutant currently
available is twofold. First, it is knocked out in only one of two genes which convert
farnesyl pyrophosphate to farnesol and thus it still produces 15% as much farnesol as its
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parent and, second, it is an arginine auxotroph (Navarathna et al., 2007a). Ghosh et al
(Ghosh et al., 2009) demonstrated the requirement of arginine biosynthesis by C.
albicans to effectively penetrate and escape murine macrophages. Briefly (Fig 1), Ghosh
et al (Ghosh et al., 2009) showed that the rapid upregulation of arginine biosynthetic
genes following macrophage ingestion, originally noted by Lorenz et al (Lorenz et al.,
2004), occurred so that the arginine could be degraded to urea and then to CO2, a known
signal for hyphal switching (Bahn and Muhlschlegel, 2006) necessary for C. albicans to
escape. Therefore, the dpp3Δ/dpp3Δ mutant and its parental strain SN152 are unable to
escape from macrophages, regardless of the presence of DPP3.

New prototrophic

mutants defective in farnesol production must be constructed before this question can be
answered.
Consistent with early hypotheses, Hisajima et al (Hisajima et al., 2008) recently
published the finding that farnesol has a protective role against C. albicans in an oral
model of murine infection. This presents an intriguing conundrum: how does farnesol
enhance infection for disseminated candidiasis (Navarathna et al., 2007a) while treating
infection for mucosal (oral) candidiasis? A similar conundrum is how farnesol can act
externally to protect yeast cells from oxidative stress (Westwater et al., 2005) but also
inhibit growth by enhancing ROS production by mitochondria (Machida et al., 1998b).
This suggests other factors are at play other than or in addition to the effect of farnesol on
C. albicans, potentially the host’s response to farnesol.
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Figure legends
Figure 1-1. Farnesol impacts the cyclic AMP pathway in C. albicans. Three possible
points of inhibition by farnesol.
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Table 1-1. The effects of farnesol treatment in other cell types.

Organism
C. dubliniensis

C. parapsilosis

Acinetobacter
baumannii
Aspergillus
fumigatus
Aspergillus
nidulans

Farnesol
Concentration(s) Summary of Farnesol Response
Used
1.5 nM- 300 µM Filament inhibition, no effect on growth,
(Henriques et al., 2007; Martins et al., 2007),
biofilm inhibition, MIC = 200µM, lowered
tolerance of fluconazole (Jabra-Rizk et al., 2006b)
1.5 nM-100 µM
Biofilm inhibition (Laffey and Butler, 2005),
growth arrest ≥50 µM, lipid metabolism,
ribosome biogenesis, and amino acid biosynthesis
genes affected, altered lipid polarization
(Rossignol et al., 2007)
50 µM- 200 µM
Growth inhibition (Peleg et al., 2008)
10 µM - 250 µM
1 µM - 250 µM

Aspergillus
niger
Fusarium
graminearum
Human gingival
cells
Human oral
carcinoma cells
Murine
macrophages
Paracoccidiodes
brasiliensis

100 µM- 10mM

Pseudomonas
aeruginosa

30 µM - 300 µM

Saccharomyces
cerevisiae

5 µM- 5 mM

Growth inhibition, apoptosis (Semighini et al.,
2006)
Apoptosis and ROS production (10 – 250 µM)
(Semighini et al., 2006), hyphal inhibition (1-10
µM) (Semighini et al., 2006), autophagy, lipid
metabolism, amino acid response, transcription,
and translation genes affected (10-100 µM)
(Savoldi et al., 2008)
Inhibition of conidiation (Lorek et al., 2008)

100 µM - 300 Apoptosis, altered spore germination and lysis
µM
(Semighini et al., 2008)
10 µM- 300 µM
Reduced proliferation and adhesion (Saidi et al.,
2006)
10 µM - 60 µM
Apoptosis (Scheper et al., 2008)
56 µM - 112 µM
5 µM - 300 µM

Apoptosis, ROS production, decreased phagocytic
activity (Abe et al., 2009)
Inhibition of yeast to hyphal and hyphal to yeast
growth at low concentrations, growth inhibition at
high concentrations (Derengowski et al., 2009)
Inhibition of Pseudomonas quinolone signal
(PQS) and pyocyanin production, decreased
swarming motility,
(Cugini et al., 2007;
McAlester et al., 2008)
Growth inhibition by cell cycle arrest, effect on
mitochondria and increased reactive oxygen
species (ROS) production (Machida et al., 1998a;
Machida et al., 1999), cell death (Fairn et al.,

21

Staphylococcus
aureus

30 µM - 4.5 mM

Staphylococcus
epidermidis
Streptococcus
mutans

100 µM -200 µM

Tobacco
(Nicotiana
tabacum L. cv
Bright Yellow2)

5 µM -150 µM

250 µM - 5 mM

2007)
Cell death, membrane disruption, biofilm
inhibition, lipase inhibition, increased sensitivity
to antibiotics (Jabra-Rizk et al., 2006a; Kuroda et
al., 2007; Togashi et al., 2008)
Cell death (Gomes et al., 2009)
Growth inhibition, biofilm inhibition, prevention
of dental caries in rats when in combination with
fluoride and apigenin (Koo et al., 2002a; Koo et
al., 2002b; Koo et al., 2003; Koo et al., 2005)
Cell death (Hemmerlin and Bach, 2000;
Hemmerlin et al., 2006)
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Table 1-2. The effects of secreted bacterial molecules on C. albicans.

Bacterium
Acinetobacter
baumannii
Burkholderia
cenocepacia
P. aeruginosa

P. aeruginosa
Salmonella
enterica
serovar
Typhimurium
Streptococcus
gordonii
Xanthomonas
campestris

Secreted
Molecule(s)
Unknown, found in
cell-free supernatant
Cis-2-dodecenoic
acid (Burkholderia
diffusible signal
factor, BDSF)
3-oxo-C12homoserine lactone,
dodecanol, and C12acyl homoserine
lactone
Phenazines
Unknown, found in
cell-free supernatant
Unknown, found in
cell-free supernatant
and missing/reduced
in ΔluxS mutant
Cis-11-methyl-2dodecenoic acid
(diffusible signal
factor, DSF)

Summary of C. albicans Response
Filament inhibition, biofilm inhibition (Peleg
et al., 2008)
Growth inhibition and filament inhibition
(Boon et al., 2008)
Filament inhibition and reversion to yeast
morphology (Davis-Hanna et al., 2008; Hogan
et al., 2004)
Cell death (Gibson et al., 2009)
Filament inhibition, biofilm inhibition, and
reduced viability (Tampakakis et al., 2009)
Induction of filamentous growth, suppression
of farnesol-mediated filament inhibition
(Bamford et al., 2009)
Filament inhibition (Boon et al., 2008; Wang
et al., 2004)
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CHAPTER 2
Activity and toxicity of farnesol on Candida albicans is dependent on growth
conditions
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Abstract
Farnesol interacts with Candida albicans as both a quorum sensing molecule and
toxic agent, but confusion abounds regarding which conditions promote these distinct
responses.

Farnesol sensitivity was measured when inoculum cell history and size,

temperature, and media were altered. Parameters for farnesol tolerance/sensitivity are
defined, validating previous studies and identifying new variables, such as energy
sources. This study provides a clear understanding of what farnesol concentrations are
lethal to C. albicans, based on environmental conditions.
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Introduction
Candida albicans is a dimorphic fungus of great medical importance. It is also
the model system for studying quorum sensing for fungal dimorphism (Hornby et al.,
2001). C. albicans excretes a quorum sensing molecule (QSM) called farnesol and when
extracellular levels exceed a threshold of 1-5 μM (Mosel et al., 2005), farnesol blocks the
yeast-to-filament conversion.

One feature of farnesol’s action as a QSM was that

exogenous farnesol up to 200-300 μM does not alter the growth rate; instead, the cells
grow as yeasts rather than as filaments.

These results were quickly confirmed by

Ramage et al (Ramage et al., 2002), Hogan et al (Hogan et al., 2004), and Kruppa et al
(Kruppa et al., 2004). Farnesol also impacts other aspects of C. albicans biology: it
blocks biofilm formation (Ramage et al., 2002), acts as a virulence factor during systemic
infection (Navarathna et al., 2007a), and is a protective factor during mucosal infection
(Hisajima et al., 2008). Farnesol production is regulated in that it is turned off in opaque
cells (Dumitru et al., 2007) and during anaerobic growth (Dumitru et al., 2004) but
elevated in some mutants which are altered in morphology (Jensen et al., 2006) or locked
in the filamentous morphology (Kebaara et al., 2008).

Farnesol production also

increases in the presence of sublethal levels of sterol biosynthesis inhibitors (Hornby and
Nickerson, 2004; Navarathna et al., 2005).
Farnesol is a bioactive molecule with mild detergent-like properties.

At

concentrations in the 20-50 μM range it has been reported to inhibit or induce cell death
in Saccharomyces cerevisiae (Machida et al., 1998a; Machida et al., 1999), Aspergillus
nidulans (Semighini et al., 2006), Fusarium graminearum (Semighini et al., 2008),
Paracoccidioides brasiliensis (Derengowski et al., 2009), and C. albicans opaque cells
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(Dumitru et al., 2007). Similarly, farnesol has been reported to trigger cell death in
several mammalian cell lines (Abe et al., 2009; Saidi et al., 2006; Scheper et al., 2008)
and bacteria (Gomes et al., 2009; Jabra-Rizk et al., 2006a; Koo et al., 2003; Togashi et
al., 2008), and it induces cytokine production, such as IL-6, by macrophages. Thus, the
view to this point was that C. albicans exhibited exceptional tolerance to farnesol, as a
necessary corollary to its production as an antagonistic molecule. This view was recently
challenged by Shirtliff et al (Shirtliff et al., 2009) who reported that farnesol, at
concentrations as low as 40 μM, killed C. albicans by inducing apoptosis. Thus, in the
spirit of constructive dialogue, we draw attention to the differences between the growth
conditions used in our previous body of work under which farnesol would act as a
signaling molecule, innocuous to growth, and the conditions under which Shirtliff et al
(Shirtliff et al., 2009) observed cell death.
Previous studies examining C. albicans sensitivity to farnesol (Dumitru et al.,
2007; Jabra-Rizk et al., 2006b; Shirtliff et al., 2009; Uppuluri et al., 2007) have used
vastly different assay conditions (varying temperatures, media, inoculum sizes, and
inoculum growth phases), adding to confusion on the matter of farnesol-induced cell
death.

Critically, Shirtliff et al (Shirtliff et al., 2009) used cells that were grown

overnight, washed and resuspended in PBS for farnesol sensitivity assays. Since it is well
known that detergent resistance in bacteria is an energy dependent process (Aspedon and
Nickerson, 1993; Rajagopal et al., 2003), we were particularly interested whether
farnesol resistance in C. albicans is similarly energy dependent.
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Methods
We examined farnesol sensitivity under a series of different growth conditions in
plastic microtiter dishes. Variables included temperature, cell density, growth medium
(rich vs. minimal), and inoculum history. We followed cell growth by means of optical
density and cell death by methylene blue staining (Gibson et al., 2009). C. albicans cells
were grown to stationary phase (unbudding cells; cultures were inoculated to an OD600
=0.1 and grown at 30°C for 16-18h) or mid-log phase (OD600 =0.5), washed three times
in PBS, and inoculated at the indicated levels with variable concentrations of farnesol.
We used 10 mM and 100 mM stocks of E, E-farnesol in methanol so that the final
methanol concentration never exceeded 1%, and this level of methanol had no effect on
cell growth or cell death (data not shown).
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Results
In rich growth medium (YPD), no cell death was observed at farnesol
concentrations up to 300 μM and growth inhibition was only observed with 300 μM
farnesol (data not shown). When we switched to a defined glucose-proline (GPP pH6.8)
(Kebaara et al., 2008)medium (Fig. 1), very similar growth curves were observed with all
concentrations of farnesol up to 300 μM when starting with stationary phase inocula (Fig.
1A). The cell growth experiments (Fig. 1) were simultaneously examined for cell death
by staining with methylene blue (Fig. 2B, 2D). Minimal cell death occurred in GPP with
a stationary phase inoculum, our standard growth conditions (Hornby et al., 2001; Mosel
et al., 2005), and up to 300 μM farnesol (Fig. 2D) consistent with growth curves seen in
Fig. 1A. However, when we used inocula of exponentially growing cells, 40 μM farnesol
partially inhibited growth and further inhibition correlated with increasing farnesol levels
(Fig. 1B). Log phase cells were killed by 100 and 300 μM farnesol in GPP (Fig. 2B),
consistent with the delayed growth seen in Fig. 1B. These results support the growth
phase-dependent sensitivity described by Uppuluri et al (Uppuluri et al., 2007).
Temperature does not play a prominent role in farnesol growth inhibition because we
obtained similar growth curves at 25ºC, 30°C, and 37°C (data not shown).
To examine the effects of different media on farnesol sensitivity, cells were
compared under both growth (GPP) and storage (PBS) conditions, using both exponential
and stationary phase inocula (Fig. 2). For exponential phase cells inoculated in PBS,
even low levels of farnesol, i.e. 40 μM, caused cell death (Fig. 2A), consistent with the
findings of Shirtliff et al (Shirtliff et al., 2009). The cells in PBS were far more sensitive
to farnesol when they had come from an exponential phase inoculum than a stationary
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phase inoculum (Fig. 2A, 2C). Interestingly, both exponential and stationary phase cells
showed increased tolerance to farnesol when incubated in growth media (GPP or YPD),
compared to PBS (Fig. 2). As with growth rates, similar results for cell death were
obtained at all 3 temperatures tested, 25°C, 30°C, and 37°C. These observations suggest
a role for energy source(s) in C. albicans farnesol tolerance.
The previous experiments (Figs. 1 and 2) were conducted in 96 well plates with
farnesol added at time zero to washed cells. Because of a possible farnesol adsorption
effect with plastic (Davis-Hanna et al., 2008), we confirmed the farnesol sensitivity of
exponentially growing cells in glass flasks (Fig. 3). We compared the farnesol sensitivity
of C. albicans cells in exponential phase (OD600 = 0.5, Fig. 3A, 3B) and stationary phase
(OD600 = 4.0, Fig. 3C, 3D) by adding farnesol directly to unwashed growing cultures.
The results with glass flasks (Fig. 3) were consistent with those obtained with plastic 96
well plates.
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Discussion
A distinct benefit of this controversy is to focus attention on the conditions in
which C. albicans tolerates farnesol while so many other cell types are killed by it.
Stationary phase C. albicans cells exhibit extreme farnesol tolerance, even at 100-300
μM farnesol, and these levels are lethal to most other organisms tested. Throughout, cell
death was not accompanied by cell lysis because there was no drop in OD600 and the
methylene blue positive cells remained intact. Similarly, optical densities of cells in PBS
were not significantly affected by the presence of farnesol (data not shown). This lack of
cell lysis with white cells of C. albicans is in marked contrast with opaque cells where ≥
40 µM farnesol caused rapid cell lysis (Dumitru et al., 2007).

The differences in

susceptibility between white and opaque cells (Dumitru et al., 2007), aerobic and
anaerobic cells (Dumitru et al., 2004), stationary and exponential cells [(Uppuluri et al.,
2007) and Figs. 1-3], and between cells in buffer alone versus minimal media suggest a
physiological adaptation to farnesol, depending on environmental conditions. Two places
where this selective farnesol tolerance might be localized are the mitochondria, where
farnesol stimulates ROS production in C. albicans and S. cerevisiae (Machida et al.,
1998a; Machida et al., 1999; Shirtliff et al., 2009), and the lipid portion of the
cytoplasmic membrane. Changes in fatty acid composition, sterol-rich domains (Alvarez
et al., 2007), sphingolipids (Brown and London, 2000), and GPI-anchored proteins
preferentially associated with lipid rafts (Brown and London, 2000) could be involved, as
supported by the lipid domain alteration seen in C. parapsilosis after farnesol treatment
(Rossignol et al., 2007). Although the mechanisms(s) involved in farnesol tolerance
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remain unclear, conditions in which C. albicans is either sensitive or resistant to farnesol
have now been outlined.
In summary, stationary phase cells inoculated into minimal or rich media are ideal
candidates for studying farnesol signaling, as these do not undergo cell death with high
farnesol concentrations.

This generalization was true for all three commonly used

temperatures (25°C, 30°C, 37°C) as well as for experiments with starting cell densities of
OD600 = 0.05 or 0.10. Conversely, optimal conditions to examine farnesol-mediated cell
death include the use of log phase cells in PBS, under energy-starved conditions.
Understanding these environmental parameters may unify many previous discrepancies
in the literature and provide unambiguous conditions to induce each of farnesol’s unique
effects on C. albicans.
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Figure Legends
Fig. 2-1. Effect of farnesol on C. albicans cell growth. A) stationary phase inoculum, B)
exponential phase inoculum. Cells were grown in duplicate on at least two separate
occasions in defined GPP medium with indicated levels of farnesol (see legend in B) at
30°C in 96-well plates, and OD600 values were recorded on an automated plate reader
(Molecular Devices, Sunnyvale, CA). Note the different y-axis scales in graphs A and B.

Fig. 2-2. Effect of farnesol on C. albicans cell death. Percent death was determined by
methylene blue staining (Gibson et al., 2009). Cells were incubated in either PBS (A, C)
or GPP (B, D) with the indicated levels of farnesol in 96-well plates at 30°C. Incubations
were initiated with either exponential (A, B) or stationary phase (C, D) inocula.

Fig. 2-3. Toxicity of farnesol to exponential cultures of C. albicans. One culture (A, B)
was subdivided (in six) when it had reached exponential phase (OD600 = 0.5) and the
other (C, D) was subdivided when it had reached stationary phase (OD600 = 4.0).
Cultures were not washed prior to subdivision and farnesol addition. Cultures containing
the indicated levels of farnesol were shaken at 30°C and 250 rpm for 4 hrs and at the
indicated times cell growth (A, C) and % dead cells (B, D) were determined. All cultures
were in glass flasks in GPP both before and after subdivision.
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CHAPTER 3
Candida albicans Tup1 is involved in farnesol-mediated inhibition of filamentousgrowth induction
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Abstract
Candida albicans is a dimorphic fungus that can interconvert between yeast and
filamentous forms.

Its ability to regulate morphogenesis is strongly correlated with

virulence. Tup1, a transcriptional repressor, and the signaling molecule farnesol are both
capable of negatively regulating the yeast to filamentous conversion. Based on this
overlap in function, we tested the hypothesis that the cellular response to farnesol
involves, in part, the activation of Tup1. Tup1 functions with the DNA binding proteins
Nrg1 and Rfg1 as a transcription regulator to repress expression of hyphal specific genes.
The tup1/tup1 and nrg1/nrg1 mutants, but not the rfg1/rfg1 mutant, failed to respond to
farnesol. Treatment of C. albicans cells with farnesol caused a small but consistent
increase in both TUP1 mRNA and protein levels. Importantly, this increase corresponds
with the commitment point, beyond which added farnesol no longer blocks germ tube
formation, and it correlates with a strong decrease in the expression of two Tup1regulated, hyphal-specific genes, HWP1 and RBT1. Tup1 probably plays a direct role in
the response to farnesol because farnesol suppresses the haploinsufficient phenotype of a
TUP1/tup1 heterozygote. Farnesol did not affect EFG1 (a transcription regulator of
filament development), NRG1, or RFG1 mRNA levels, demonstrating specific gene
regulation in response to farnesol. Further, the tup1/tup1 and nrg1/nrg1 mutants produced
17- and 19-fold more farnesol, respectively, than the parental strain. These levels of
excess farnesol are sufficient to block filamentation in a wild-type strain. Our data are
consistent with Tup1 being a crucial component of the response to farnesol in C.
albicans.
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Introduction
Candida albicans is the most commonly isolated opportunistic fungal pathogen in
humans. C. albicans is part of the normal flora, and it resides in the gastrointestinal and
genitourinary tracts, as well as on the skin. However, C. albicans is capable of causing a
wide range of disease, from mild mucosal infections to life-threatening systemic
infections termed candidemia (Jarvis and Martone, 1992). Vulnerable patients include
AIDS patients, patients undergoing chemotherapy, and organ transplant patients (Jarvis
and Martone, 1992). The annual cost of treating candidiasis in the United States was
estimated to be one billion dollars, and the mortality rates for patients with candidiasis
are 30-50% even with antifungal treatment (Kullberg and Filler, 2002), indicating a need
for new antifungal drugs.
The ability of C. albicans to cause disease has been strongly linked to its
conversion between two distinct morphological forms: yeast and filaments. Recently,
our research has focused on farnesol, the first quorum sensing molecule (QSM)
discovered in a eukaryote (Hornby et al., 2001).

Farnesol is a virulence factor

(Navarathna et al., 2007a) that is excreted continuously by C. albicans (Hornby et al.,
2001), and when it accumulates beyond a threshold level it blocks the yeast to filament
conversion (Hornby et al., 2001). Stationary phase cultures of C. albicans have
accumulated 2-4 µM farnesol (Hornby et al., 2001) and the IC50 value for blocking germ
tube formation (GTF) in an N-acetylglucosamine stimulated assay is ca. 1-2 µM (E, E)
farnesol (Hornby et al., 2001; Mosel et al., 2005; Shchepin et al., 2003) and,
consequently, these farnesol production levels are physiologically relevant. Other roles
described for farnesol include biofilm inhibition (Ramage et al., 2002), protection from
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oxidative stress (Deveau et al., 2010; Westwater et al., 2005), and induction of apoptosis
in another fungus, Aspergillus nidulans (Semighini et al., 2006).

While many

phenotypic effects produced by farnesol have been described, little is understood about
farnesol’s mode of action.
In addition to farnesol, C. albicans yeast and filamentous growth is controlled by
an assortment of signaling pathways (Berman and Sudbery, 2002; Dhillon et al., 2003).
The yeast to filamentous conversion is activated by many pathways, including:
Components of the CEK1 MAP kinase pathway, Ras/cAMP-dependent pathway,
Calcium/Calmodulin signaling pathway, Rim101-independent pathway, and Chk1 twocomponent signal transduction pathway. Although each has been implicated in
filamentation (Csank et al., 1998; Kruppa et al., 2004; Ramon et al., 1999), these
pathways show some degree of specialization in that they respond to different
environmental inducers. Activation and inhibition of filament development is largely
accomplished through changes in gene expression mediated by transcription activators
and repressors. Efg1 is a major transcription regulator of filamentous growth and is a
central control point for many signaling pathways involved in filamentation (Eckert et al.,
2007). Efg1 also regulates the expression of multiple genes including those involved in
virulence (Eckert et al., 2007; Kumamoto and Vinces, 2005a). Mechanisms have also
been identified that block filament development with transcriptional repression by Tup1
playing a key role (Braun and Johnson, 1997; Braun and Johnson, 2000).
Farnesol is able to block filamentous growth induced by environmental signals for
most, and possibly all of the signaling pathways activating filament development. These
signals include: 10% serum, 10 mM L-proline, 2.5 mM N-acetylglucosamine, or the
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combination of N-acetylglucosamine and L-proline, all at 37oC (Hornby et al., 2001).
Thus, farnesol may individually block each of the morphogenic signaling pathways
and/or act at a common control point in morphogenesis. Tup1 repression of filament
specific genes is an attractive candidate for a common control point that may be regulated
by farnesol (Kadosh and Johnson, 2005).
The C. albicans Tup1 protein is a transcription regulator that plays two key roles
in the cell: 1) regulation of phase switching, and 2) inhibition of filamentous growth.
Tup1 interacts with either Ssn6 or Tcc1 corepressor proteins. This complex functions
with DNA binding proteins to repress gene expression (Kaneko et al., 2006; Sprague et
al., 2000). At least three DNA-binding proteins have been identified that function with
Tup1: Nrg1 (homologous to Saccharomyces cerevisiae Nrg1p), Rfg1 (homologous to S.
cerevisiae Rox1p), and Mig1 (homologous to S. cerevisiae Mig1p). Homozygous tup1
mutants are unable to grow as yeast and instead remain locked in the filamentous form in
all media tested (Braun and Johnson, 1997).

Deletion of TUP1 results in the up-

regulation of approximately one-third of C. albicans genes (Murad et al., 2001a; Murad
et al., 2001b) and these mutants are also avirulent in a murine model of infection.
Activation of Tup1 transcription repressor complexes results in the repression of
filament-specific gene expression (Braun and Johnson, 1997; Braun and Johnson, 2000;
Murad et al., 2001a; Murad et al., 2001b).
Here, we tested the hypothesis that the C. albicans response to farnesol involves
Tup1. The morphological response to farnesol was tested in wild-type, tup1/tup1,
tup1/TUP1, nrg1/nrg1, and rfg1/rfg1 strains to assess the requirement for these genes in
the farnesol response. The gene expression pattern for MIG1 was not determined because
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Mig1 protein does not play a role in filamentous growth of C. albicans (Murad et al.,
2001a). The gene expression patterns of TUP1, NRG1, RFG1, and EFG1, as well as
genes under their control were examined in the presence or absence of farnesol by
quantitative northern and western analyses. Finally, we compared farnesol production
levels in tup1, nrg1, and rfg1 homozygous mutants relative to wild type cells.
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Methods
Strains and media
Candida albicans SC5314 is an independent clinical isolate and the reference
strain

for

the

Candida

genome

sequence.

C.

albicans

strains

CAF-2

(ura3:imm434/URA3) and CAI-4 (ura3::imm434/ura3::imm434) are derived from
SC5314 by gene replacement .

Strains BCa2-9 (tup1/tup1, in CAI-4; (Braun and

Johnson, 1997), BCa2-10 (tup1/tup1, frameshift disruption fragment in CAI-4; (Braun
and Johnson, 1997), DU152 (nrg1/nrg1, in CAI-4; (Braun and Johnson, 1997), DU129
(rfg1/rfg1, in CAI-4; (Backen et al., 2000; Kadosh and Johnson, 2001), BCa05 that
expresses TUP1 ectopically (tup1/tup1, MAL3:p455, in CAI-4; (Braun and Johnson,
1997) and BCa2-3 (TUP1/tup1, in CAI-4; (Braun and Johnson, 1997) were obtained from
Alexander Johnson, University of California, San Francisco, CA. Strain MEN was
provided by Richard Cannon, University of Otago, Dunedin, New Zealand.
Resting cells were obtained by growing cells in modified glucose salts biotin
media (mGSB) overnight, washing three times with 50 mM phosphate pH 6.5,
resuspended in 10 ml of 50 mM phosphate, and stored at 4°C to be used within a month.
The defined glucose-salts medium GPP pH 4.8 contained (per liter distilled
water): glucose, 20g; L-proline, 1.15g; NaH2PO4, 3.2g; KH2PO4, 4g; MgSO4•7H20, 0.5g;
CuSO4•5H20, 1mg; ZnSO4•7H20, 1mg; MnCl2, 1mg; FeSO4, 1 mg; biotin, 20 μg;
pyridoxine•HCl, 200 μg; thiamine•HCl, 200 μg,. The glucose (20% w/v) and L-proline
(100 mM) were autoclaved separately and added aseptically, as were the filter-sterilized
vitamins (Kulkarni and Nickerson, 1981). Modified GPP (mGPP) also contained 2.5 mM
N-acetylglucosamine (Hornby et al., 2001). GPP pH 6.8 contained 3.2g/L Na2HPO4
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instead of NaH2PO4.

For maltose phosphate proline media (MPP), filter-sterilized

maltose replaced the glucose. Cornmeal agar (Difco, Detroit, MI) was also used. Solid
media included 1.5% (w/v) agar. All media for CAI-4 included uridine at 40 μg/ml
(Backen et al., 2000).
Microscopy
Differential interference contrast (DIC) images were photographed with an
Olympus BX51 microscope and colony morphology images were photographed with an
Olympus SZX12 microscope.
Quantitative Northern blot analysis
To measure mRNA accumulations, SC5314 resting cells were inoculated in
mGPP to an OD600 of 0.5-0.6 and allowed to equilibrate at 37°C for 5 minutes whereupon
20 μM farnesol was added to half of the flasks. Cells were grown at 37°C for 0, 20, 40,
60, and 80 minutes until the cells were harvested and total RNA extracted by the hot
phenol method (Backen et al., 2000; Kebaara et al., 2003). Equal amounts of RNA
(15μg) were resolved on 1.0 % agarose-formaldehyde gels and the RNA was transferred
to GeneScreen Plus (NENTM Life Science Products, Inc., Boston, MA) using the capillary
blot transfer protocol recommended by the manufacturer. The Northern blots were probed
with radiolabeled DNA probes. The probe DNAs used for synthesis were prepared by
PCR using MEN genomic DNA. The probes were labeled with
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P-dCTP (GE Health

Sciences, Piscataway, NJ) using an oligolabeling kit, RadPrime DNA labeling system
following the protocol recommended by the manufacturer (Invitrogen, Carlsbad, CA).
Northern blots were PhosphorImaged using a Storm (Amersham Pharmacia Biotech Inc.,
Piscataway, NJ) and quantified using ImageQuant software (Molecular Dynamics version
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5.0, Sunnyvale, CA). mRNA abundance measurements were done using a minimum of
three independent Northern blots.
Western blot analysis
Western blots were prepared as previously described (Atkin et al., 1995) and
Tup1 and Act1 proteins detected with the Supersignal® West Pico Chemiluminescent
Substrate using the manufacturers protocol (Pierce, Rockford, IL) with the exception that
blocking was done with 5% nonfat dry milk. Rabbit polyclonal antibodies against Tup1
were previously described (Inglis and Johnson, 2002). Mouse monoclonal Anti-Act1
antibodies and horseradish peroxidase (HRP) labeled ant-rabbit IgG antibodies were from
Amersham Pharmacia Biotech Inc. (Piscataway, NJ). HRP labeled anti-mouse antibody
was from Perkin-Elmer (Boston, MA).
Analysis of farnesol levels
Extracellular farnesol was extracted from cell free-supernatants of cultures grown
in mGPP at 30o and analyzed by GC/MS as described (Hornby et al., 2001).
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Results
tup1/tup1 and nrg1/nrg1 mutants lack a morphological response to farnesol while
the rfg1/rfg1 mutant responds to farnesol
The juxtaposition of farnesol’s ability to inhibit differentiation, and the role of
Tup1 as a transcription repressor for filamentation genes suggests that farnesol could
function by activating Tup1 and/or one of its co-regulators, Nrg1 and Rfg1.
Consequently, we examined the effect of farnesol on the morphology of null mutants
lacking TUP1, NRG1, and RFG1. As a control, the wild type C. albicans SC5314 in
filament-inducing media grew as yeasts in the presence of 20 μM farnesol and as
filaments in media lacking farnesol, demonstrating a positive response to farnesol (Fig.
1). The rfg1/rfg1 mutant responded to 20 μM farnesol in a similar manner to SC5314
(Fig. 1). Unlike SC5314 and rfg1/rfg1, the tup1/tup1 and nrg1/nrg1 mutants lacked a
detectable response to farnesol and remained filamentous in the presence of 20 μM
farnesol (Fig. 1). The filamentous-only cell morphology is the expected phenotype for
these known mutants (Braun and Johnson, 1997; Braun et al., 2001; Khalaf and Zitomer,
2001; Murad et al., 2001a; Murad et al., 2001b). However, in this regard, tup1/tup1 and
nrg1/nrg1 mutants differ from the great majority of filamentous-only mutants recovered
from a previous study, 96% of which reverted to a smooth colony (yeast) morphology on
YM agar plates with 50 μM farnesol (Jensen et al., 2006). For the tup1/tup1 mutant, the
lack of response to farnesol was specific for loss of Tup1 because we found ectopic
expression of TUP1 (Braun and Johnson, 1997) restores the ability to respond to farnesol
(data not shown).
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TUP1 mRNA levels increase in the presence of farnesol while RFG1 and NRG1
mRNA levels were not affected by farnesol
We analyzed the effect of farnesol on TUP1 mRNA levels over time in C.
albicans SC5314 cells which had been induced to differentiate from yeasts to filaments
by growth at 37°C in mGPP. We previously showed (Mosel et al., 2005) that, in these
conditions, the first germ tubes appeared at 30 min and the process was complete by 110
min. Further, farnesol no longer blocked germ tube formation when added 60-90 min
after inoculation (Kulkarni and Nickerson, 1981).

Here our analysis was designed to

evaluate changes in TUP1 mRNA just before germ tube formation when the cells were
still responsive to farnesol. Filamentation was induced by transferring resting cells into
mGPP (pH 4.8) at 37°C in the presence and absence of 20 μM farnesol and mRNA levels
were determined at 0, 20, 40, 60 and 80 min following induction. In all experiments, the
TUP1 mRNA levels decreased over the first 20 min and then increased (Fig. 2A). This
pattern is consistent with the single time point results of Toyoda et al. (Toyoda et al.,
2004) who showed that TUP1 mRNA levels increased slightly at 180 minutes after
induction of filamentation. In the presence of farnesol, we found that TUP1 mRNA
consistently increased 2.5±0.6 (n=4) fold from 20 to 60 min. Importantly, this is the time
period just prior to that at which the cells become committed and are no longer
responsive to farnesol (Mosel et al., 2005). In contrast, in the absence of farnesol, there
was very little increase (1.4±0.3, n=4) in TUP1 mRNA levels from 20 to 60 min (Fig
2A). Thus, farnesol (20 µM) causes a consistent increase in TUP1 mRNA levels during
the precise time period when it blocks differentiation from yeasts to filaments. This
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increase of 2.5-fold in TUP1 mRNA corresponded to an increase in SC5314 Tup1 protein
levels at 60 min following induction (Fig.3). Tup1 protein in SC5324 was increased in
all three replicate experiments by an average of 2.5-fold.
Since Tup1 functions with DNA binding proteins such as Rfg1 or Nrg1, and in C.
albicans strain JCM9061 NRG1 mRNA levels decreased during filamentation (Toyoda et
al., 2004), we tested the effect of farnesol on RFG1 and NRG1 mRNA levels during
differentiation from yeasts to filaments.

Like TUP1, RFG1 mRNA levels initially

decreased and then increased (data not shown). However, unlike TUP1, the timing and
magnitude of the changes were similar in the presence and absence of farnesol (Fig. 4,
data not shown). Under the same conditions, NRG1 mRNA levels did not change during
development and they too were the same in the presence and absence of farnesol (Fig. 4).
Thus, we conclude that farnesol does not affect RFG1 or NRG1 mRNA levels.

Expression of the Tup1-regulated filamentous genes HWP1 and RBT1 is inhibited
by farnesol
To test whether the increased TUP1 expression in the presence of farnesol was
biologically significant, we examined the expression of two Tup1-regulated genes, HWP1
and RBT1 [Fig. 2B and C, (De Groot et al., 2003)]. In the absence of farnesol, the HWP1
and RBT1 transcripts were undetectable at time 0 but they were strongly expressed from
40 to 80 minutes (Fig. 2B and C).

Farnesol delays and dramatically reduces the

magnitude of HWP1 and RBT1 mRNA expression (Fig. 2B and C). At 80 minutes,
HWP1 and RBT1 levels were 30- and 7.6-fold lower, respectively, in farnesol treated than
untreated cells. Similar results were observed by Davis-Hanna et al. (Davis-Hanna et al.,
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2008) for HWP1 mRNA 2 hours after treatment with 75 μM farnesol. Thus there is a
strong correlation between elevated TUP1 expression in response to farnesol and the
expression of Tup1-regulated genes.

EFG1 mRNA levels remain unaffected by farnesol
Efg1 is a transcription regulator for genes required for filamentation. EFG1
mRNA levels are down regulated at the initiation of filament development and then
increase as filament formation progresses (Tebarth et al., 2003). HWP1 and RBT1 are
activated by Efg1 during filamentation.

Therefore, we tested whether farnesol also

affects EFG1 mRNA levels (Fig. 4). The EFG1 mRNA levels were high at time 0,
decreased to a minimum at 20 minutes, and then increased steadily throughout the
remaining time (data not shown). However, farnesol had no influence on EFG1 mRNA
levels since the timing and magnitude of the changes were similar in the presence and
absence of farnesol (Fig.4 and data not shown).

Farnesol suppresses the haploinsufficient phenotype of a TUP1/tup1 heterozygote.
Braun and Johnson (Braun and Johnson, 1997) showed that BCa2-3, a TUP1/tup1
heterozygote, is haploinsufficient in that these cells develop a higher proportion of
filaments compared to wild-type cells on most media (Braun and Johnson, 1997).
Presumably these cells do not make enough Tup1 to compensate for the reduced gene
copy number. We hypothesized that farnesol might suppress this phenotype because it
increases TUP1 expression 2.5-fold in SC5314 and 4.2 fold in TUP1/tup1 (Fig. 3). This
increase should restore Tup1 to roughly wild type levels. To test this hypothesis, we
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examined the effect of farnesol on C. albicans BCa2-3 on cornmeal agar plus Tween 80
under a coverslip for 25 hours at 25°C. In these conditions, the TUP1/tup1 mutant was
more filamentous than wild-type colonies but less filamentous than the tup1/tup1 mutant
(BCa2-10; 4 and Table 2). As a control, we showed the TUP1/tup1 mutant responds to
farnesol because, although it forms filamentous cells when grown in mGPP, the addition
of 20 μM farnesol results in growth as yeasts (Fig. 1), and Tup1 protein levels were ca.
4.2-fold higher in the TUP1/tup1 mutant treated with farnesol. In contrast to the
haploinsufficient phenotype observed in the absence of farnesol, in the presence of
farnesol the TUP1/tup1 mutant looked identical to wild type C. albicans (Table 2). Thus
farnesol suppresses the haploinsufficiency phenotype of the TUP1/tup1 heterozygote.

tup1/tup1 and nrg1/nrg1 mutants produce excess farnesol.
Jensen et al (Jensen et al., 2006) tested the farnesol production levels for several
filamentous-only mutants.

A subset of these mutants produced levels of farnesol

significantly higher than wild type strains. This overproduction suggests the ability to
respond to farnesol may be linked to regulation of farnesol production. Here we tested
farnesol production levels in CAI-4, CAF-2, tup1/tup1, nrg1/nrg1, and rfg1/rfg1 strains.
Farnesol production levels were dramatically increased in the tup1/tup1 and nrg1/nrg1
mutants (Table 1) that were unable to respond to farnesol (Fig. 1). The tup1/tup1 and
nrg1/nrg1 mutants produced ca. 17- and 19-fold more farnesol, respectively, than did
CAF-2 and CAI-4. In contrast, the farnesol responsive rfg1/rfg1 mutant only produced
ca. 2.6-fold more farnesol than the wild-type strains (Table 1). Thus, the two mutants
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that are unable to respond to farnesol (tup1/tup1 and nrg1/nrg1) produced much higher
levels of farnesol than did strains that do respond to farnesol.

tup1/tup1 overproduction of farnesol inhibits SC5314 filamentation.
We tested the biological significance of farnesol overproduction by sequentially
plating tup1/tup1 and SC5314 next to one another and observing the resultant colony
morphologies. When SC5314 was plated and followed one day later by another streak
with SC5314, a small area of filament inhibition was observed (Fig. 5A). In contrast,
when tup1/tup1 was plated first, followed by SC5314, a much larger area of filament
inhibition was observed (Fig. 5B). These results are consistent with the tup1/tup1
overproduction of farnesol. As controls, whenever tup1/tup1 was plated second, no
filament inhibition was observed (Fig. 5, C and D).
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Discussion
C. albicans responds to farnesol, in part, by changing gene expression (Cao et al.,
2005; Enjalbert and Whiteway, 2005). We hypothesize that some of these changes are
mediated by changes in the activity of the signaling pathways regulating morphogenesis.
Here we show that the tup1/tup1 and nrg1/nrg1 null mutants are strictly filamentous and
the cells remain filamentous in the presence of added farnesol (Fig. 1). In these cases the
total farnesol levels are actually much higher than the added farnesol because the mutants
themselves produce elevated levels of farnesol (Table 1, see below). Further, Tup1
mRNA and protein levels increased in the presence of farnesol while two Tup1-regulated
genes, HWP1 and RBT1 mRNA levels decrease (Fig. 2, and 3). Importantly, the timing
of this increase (40-60 min, Fig. 2) corresponds with the commitment point, beyond
which added farnesol no longer blocks germ tube formation (Mosel et al., 2005). Finally,
we believe that Tup1 is part of the farnesol response pathway because farnesol suppresses
the haploinsufficient phenotype of a TUP1/tup1 strain (Table 2).
Cell synchrony, farnesol concentration, and timing were all important
considerations for our experimental design.

Previous work examining farnesol-

dependent changes in the global transcription profiles of developing biofilms (Cao et al.,
2005; Enjalbert and Whiteway, 2005) and during resumption of growth following
stationary phase (Enjalbert and Whiteway, 2005) were done with mixed cell populations
that differed in their ability to respond to farnesol. Further, the effect of farnesol addition
on the global gene expression during biofilm formation was determined at a single time
point, 24 hours after addition of farnesol (Cao et al., 2005). This point is significant
because such a study could only measure stable long-term farnesol-dependent changes in
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gene expression. Timing is also important because of the commitment phenomenon.
This is the point at which a switch in the environmental stimulus no longer causes the
expected switch in morphology (Chaffin and Wheeler, 1981; Mitchell and Soll, 1979;
Mosel et al., 2005). It is relevant to farnesol’s mode of action because, while farnesol
blocks the yeast to filament switch, it does not block the elongation of preexisting
filaments (Mosel et al., 2005). Thus for our experiments, we added farnesol at time zero
in order to avoid commitment to filamentous growth, and we harvested cells at 20 minute
increments to observe changes in transcript levels during the early stages of the farnesol
response (Mosel et al., 2005). We also achieved a synchronous cell population by
starting with resting cells and inoculating them in mGPP; in these conditions we routinely
get 95-100% filaments within 3-4 hrs.

Exposing a synchronized cell population to

farnesol allowed us to detect subtle and consistent changes in transcript abundance.
Small changes in expression of a transcription regulator can have profound effects
on the genes it regulates. For example, we have shown that nonsense-mediated mRNA
decay (NMD) in S. cerevisiae regulates accumulation of the mRNA for Adr1, a
transcription regulator of the genes responsible for making acetyl CoA and NADH from
nonfermentable substrates.

In particular, the respiratory impairment seen in NMD

mutants is due, in part, to overexpression of Adr1 (Taylor et al., 2005). The change in
ADR1 mRNA levels is small (2.6-fold), but sufficient to affect expression of Adr1regulated genes. Thus even though the change in Tup1 expression is relatively small it
can have a profound effect on expression of the genes it regulates.
Two Tup1 co-regulators, encoded by NRG1 and RFG1, were unaffected by
farnesol at the mRNA level (Fig. 4). In this regard, it is reasonable that farnesol regulates
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only one part of the complex, i.e. that farnesol elevates TUP1 mRNA but not NRG1 or
RFG1 mRNA. By analogy, for Ca2+ and calmodulin where only the Ca2+-calmodulin
complex is active (Soto et al., 2004a), fungi have the calmodulin in excess and regulate
the activity of the complex by regulating the availability

of cytoplasmic Ca2+

(Muthukumar et al., 1987).
Because the tup1/tup1 and nrg1/nrg1 mutants did not respond to farnesol, it
suggests that farnesol acts through a pathway requiring Tup1 and Nrg1. The rfg1/rfg1
mutant responded to farnesol, indicating that the genes regulated by Rfg1 are not required
for the response to farnesol.

Furthermore, the tup1/tup1 and nrg1/nrg1 mutants

overproduced farnesol while the rfg1/rfg1 mutant produced only slightly elevated
farnesol (Table 1). This tup1/tup1 mutant overproduction is biologically significant
because the excess farnesol produced by the tup1/tup1 mutant inhibits filamentation of
wild-type C. albicans grown on the same plate (Fig. 5). The juxtaposition between
farnesol non-responsive mutants and the overproduction of farnesol implies that a
farnesol-Tup1 feedback loop may exist, and that Nrg1 may work in concert with Tup1 to
negatively regulate farnesol synthesis. This regulation may be direct or indirect. The
enzyme responsible for ca. 90% of farnesol synthesis is Dpp3 (Navarathna et al., 2007a).
DPP3 mRNA levels were not significantly elevated in the whole genome profiles of
tup1/tup1 or nrg1/nrg1 mutants (Kadosh and Johnson, 2005); however, DPP3 does have
a putative Nrg1 binding site in its promoter region.
The increased TUP1 expression we observed for farnesol blockage of filament
development (Fig. 2A) is smaller than that reported for farnesol blockage of biofilm
development, ca 6.6-fold as determined with DNA arrays (Cao et al., 2005).

The
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difference in the response intensity may reflect filamentous vs. biofilm growth conditions
as well as the fact that Cao et al. (Cao et al., 2005) used one time point 24 hours after
farnesol addition.
Efg1 is a transcriptional factor that activates hyphal gene expression including
HWP1 and RBT1. EFG1 mRNA levels are regulated during filamentation, but they were
not affected by farnesol since the timing and magnitude of the changes were similar in
the presence and absence of farnesol (Fig. 4). These results are consistent with those of
Soto et al (Soto et al., 2004b) who also found no change in EFG1 mRNA levels at a
single time point with added farnesol (Soto et al., 2004b). Together with our results, this
suggests that farnesol does not regulate EFG1 mRNA levels but, at this time we can not
exclude the possibility that post translational regulation of Efg1 is affected by farnesol.
Two other farnesol-related findings regarding filamentous growth can be
accommodated in a Tup1-dependent model because they are downstream from Tup1.
Soto et al (Soto et al., 2004b) suggested that farnesol acts by causing decreased CPH1
and HST7 mRNA levels. CPH1 is a transcription factor that regulates filamentous growth
and HST7 is a MAP kinase kinase involved in filamentous growth. Both are downregulated by Tup1 and thus their downregulation by farnesol (Soto et al., 2004b) is
consistent with a secondary effect of farnesol on Tup1. Additionally, Chk1, a histidine
kinase shown to be required for the farnesol response (Kruppa et al., 2004), is also a
Tup1 repressed gene; CHK1 was elevated 6.5-fold in the tup1/tup1 mutant (Kadosh and
Johnson, 2005).

Taken together, these findings indicate that Tup1 is involved in

mediating the C. albicans response to farnesol.
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Figure Legends
Figure 3-1. Response to farnesol by C. albicans in conditions that promote germ tube
formation and hyphal growth.

SC5314, CAI4, CAF2, rfg1/rfg (DU129), nrg1/nrg1

(DU152), tup1/tup1(BCa2-9), tup1/tup1 (BCa2-10) and TUP1/tup1 (BCa2-3) resting
cells were inoculated to mGPP (pH 4.8) medium at 37°C in the presence or absence of 20
µM farnesol, and their cell morphology examined at 4 hours. Scale bar = 10µm

Figure 3-2. TUP1 mRNA levels increased, while two Tup1-regulated genes, HWP1 and
RBT1 were downregulated in the presence of farnesol. C. albicans SC5314 resting cells
were inoculated into mGPP (pH 4.8) in the presence or absence of 20 μM farnesol and
incubated at 37°C. Cells were then harvested at 0, 20, 40, 60 and 80 minutes post
inoculation. Northern blots were prepared with total RNA from cells incubated both in
the presence or absence of farnesol. Shown is a PhosphorImage of a representative
Northern blot probed with radiolabeled TUP1 DNA (A), HWP1 DNA (B) and RBT1
DNA (C), and a plot of average mRNA levels from a minimum of three independent
experiments. ACT1 mRNA levels were used as a loading control.

Figure 3-3. Tup1 protein levels are higher in the presence of farnesol. Total protein
extracts were prepared from SC5314 and TUP1/tup1 (BCa2-3) resting cells inoculated to
mGPP (pH 4.8) medium at 37°C in the presence or absence of 20 µM farnesol and
incubated at 37°C for 60 minutes. The average fold Tup1 protein accumulation for
farnesol treated cells relative to untreated cells is shown. Act1 levels were used as a
loading control.
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Figure 3-4. Farnesol does not affect expression of RFG1 or NRG1, which encode DNA
binding proteins that function with Tup1, or EFG1, which encodes a transcription
activator of hypal-specific genes.

Quantitative Northern blot analysis was used to

measure TUP1, NRG1, RFG1, and EFG1 mRNA levels in SC5314 at 60 min after
inoculation of resting cells into conditions that promote germ tube formation and hyphal
growth in the presence and absence of 20μM farnesol. The results are an average of three
independent experiments.

Figure 3-5.

Overproduction of farnesol by the tup1/tup1 mutant inhibits SC5314

filamentation. Resting cells were grown at 37 °C for 24 hours on YPD agar plates to
allow for farnesol accumulation in the agar (horizontal streak, C.albicans strain SC5314
(B, C), or tup1/tup1 (BCa2-10, A, D)). Subsequently, either SC5314 (A, B) or
tup1/tup1(C, D) resting cells was plated (vertical streak) and incubated at 37 °C for an
additional 24 hours. Area above the two arrows (left panels A, B) are zones of filament
inhibition (as evident by smooth morphology) resulting from the farnesol produced by the
horizontally streaked strains. Filamentation gives the wrinkled colony morphology seen
below the arrows. The pictures in the two white boxes have been magnified 2.5X so that
the colony morphology can be seen more clearly (center panels A, B). Micrographs of
individual cells from the two bracketed regions are shown in the right panels (A, B; scale
bar = 10μm). The cells from the smooth regions are mainly yeasts, while there is a much
larger proportion of filaments in the wrinkled region.
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Table 3-1. tup1/tup1 and nrg1/nrg1 null mutants do not respond to farnesol but overproduce
farnesol.
C. albicans strain

Farnesol responsea/

Farnesol productionb/

(CAI-4)

Positive

1.6 ± 0.36

(CAF-2)

Positive

2.0 ± 1.30

tup1/tup1(BCa2-10)

Negative

30.6 ± 6.40

17

nrg1/nrg1 (DU152)

Negative

34.5 ± 12.2

19

rfg1/rfg1 (DU129)

Positive

4.8 ± 2.0

2.6

a/

Fold increase in farnesolc/

Farnesol responses on GPP agar with and without 20μM farnesol incubated at 37oC for

48 hours. A positive response to farnesol indicates smooth colony morphology (yeast
cells) in the presence of farnesol and rough colony morphology (filamentous cells)
without added farnesol.

A negative response to farnesol indicates rough colony

morphology in the presence and absence of farnesol.
b/

Farnesol production (μg/g dry weight of cells) was the average of three measurements

c/

Values based on fold increase over 1.8, the average value for CAI-4 and CAF-2 strains.
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Table 3-2. Farnesol suppresses the haploinsufficient phenotype of a TUP1/tup1
heterozygote. Cells were plated on a cornmeal agar plus Tween 80 plate under a coverslip
and grown at 25°C for 25 hours.
C. albicans Strain

Cell morphology at the colony periphery
No Farnesola/

20 μM Farnesol

Wild type (SC5314)

Yeasts + few filaments

Yeast + few filaments

TUP1/tup1 (BCa2-3)

Yeasts + filaments

Yeast + few filaments

tup1/tup1 (BCa10)

filaments

filaments

a/

The phenotype for these strains grown on a cornmeal agar plus Tween 80 plate under a

coverslip without farnesol was also previously reported (Braun and Johnson, 1997).
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CHAPTER 4
A novel role for Czf1 in farnesol tolerance and the morphological response to
farnesol in Candida albicans
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Abstract
Candida albicans is the primary cause of hospital acquired fungal infections in
the United States. The quorum sensing phenomenon in Candida albicans is a process
that inhibits the transition to filamentous growth and may be directly related to its ability
to cause both mucosal and systemic disease. The Ras1-cyclic AMP signal transduction
pathway is a proposed target for farnesol inhibition, resulting in filamentous growth
obstruction, but a clear understanding of the downstream effectors and signaling
networks vital for the morphological farnesol response have yet to be unraveled. To
address this issue, we screened a mutant library for farnesol resistant mutants; among the
resistant mutants was a czf1Δ/czf1Δ mutant. Here, we demonstrate for the first time the
capability of C. albicans to respond to farnesol in embedded conditions, and in these and
liquid assays, Czf1 was required for a wild-type farnesol response. The CZF1 mRNA
transcript levels in response to farnesol, farnesol toxicity, and farnesol production levels
were also examined. Finally, CZF1 ectopic expression restored farnesol response in
strains lacking Czf1, highlighting a new role for Czf1 as a critical downstream effector of
the morphological response to farnesol in C. albicans.
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Introduction
Candida albicans is an opportunistic pathogen that is part of the normal flora but
can cause mild to severe opportunistic infections in immunocompromised patients. A
polymorphic fungus, C. albicans can switch between yeast and filamentous forms of
growth, and this transition is necessary for causing disease in a mouse model of infection
(Lo et al., 1997; Saville et al., 2003).

Two additional growth morphologies in C.

albicans include mating-competent opaque cells and structures with unknown function
called chlamydospores. All of these cell types are affected by the quorum sensing
molecule, farnesol, highlighting its influential role in C. albicans morphology.
Farnesol was the first eukaryotic quorum sensing molecule identified and was
initially shown to block the transition from yeast to filaments (Hornby et al., 2001).
Subsequent studies identified farnesol as having an inhibitory role in biofilm formation
(Ramage et al., 2002) and a protective role against oxidative stress (Deveau et al., 2010;
Westwater et al., 2005).

In addition, very high levels of farnesol can increase

chlamydospore formation (Martin et al., 2005), and low levels of farnesol induces
necrosis in opaque cells when oxygen is present, thereby regulating opaque cell stability
(Dumitru et al., 2007).

White cells can also be killed by farnesol in the right

environmental conditions; log phase cells that are energy-deprived are particularly
sensitive, while stationary phase cells in growth medium are quite farnesol tolerant
(Langford et al., 2010; Shirtliff et al., 2009; Uppuluri et al., 2007). Given its important
role in physiology, it comes as no surprise that in vivo studies provide physiological
relevance for farnesol signaling during infection and suggest farnesol plays distinct roles
at different sites of infection.

For example, farnesol is a virulence factor in a
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disseminated mouse model of infection (Navarathna et al., 2007a), yet it protects mice
from oral candidiasis (Hisajima et al., 2008). These results highlight the need for a
complete understanding of the signaling response induced by farnesol in C. albicans.
Factors identified that play a role in the C. albicans farnesol response include
Tup1/Nrg1 (Kebaara et al., 2008), Chk1 (Kruppa et al., 2004), the Hog1 MAP kinase
pathway (Smith et al., 2004), the Cek1 MAP kinase pathway (Roman et al., 2009), and
the Ras1-cyclic AMP (cAMP) signaling pathway (Davis-Hanna et al., 2008). In this
paper, we have identified Czf1 (C. albicans zinc finger) as an important factor in the
response to farnesol by screening a mutant library for mutants with a defective farnesol
response. Known roles of Czf1 include induction of contact-induced filamentous growth
(Brown et al., 1999), biofilm formation (Stichternoth and Ernst, 2009), and white to
opaque cell switching (Vinces and Kumamoto, 2007). It contains an unusually large 5’
untranslated region (UTR) of approximately 2 kb (Vinces et al., 2006), and can
negatively regulate its own mRNA expression (Vinces et al., 2006). Czf1 also has ties to
the cAMP pathway, as a transcription factor downstream of cAMP signaling, Efg1, can
bind the promoter of CZF1 and tightly regulate its expression, since no CZF1 mRNA was
detected in an efg1Δ/ efg1Δ background (Vinces et al., 2006). This positive regulation by
Efg1 is intriguing because Czf1 and Efg1 appear to play opposing roles in the cell with
respect to morphology (Giusani et al., 2002; Noffz et al., 2008). Of note, regulation
between Efg1 and Czf1 may also occur at the protein level as well since these two
proteins interact during a yeast two hybrid assay (Giusani et al., 2002; Noffz et al., 2008).
Here we have defined a new role for Czf1 in the quorum sensing response of C.
albicans.

We show that Czf1 is not only necessary for a wild type morphological
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response to farnesol in a variety of conditions, but in combination with Efg1, is required
for farnesol tolerance as well. Our data suggest a vital downstream role for Czf1 in the
signaling cascade elicited by farnesol in C. albicans.
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Methods
Strains and media
Candida albicans strains and plasmids are listed in Table 1. The defined medium,
modified glucose phosphate proline (mGPP) pH 6.8 was prepared as described in
Kebaara et al (Kebaara et al., 2008) with 2.5 mM N-acetylglucosamine (GlcNAc) and
uridine (40 µg/ml). Yeast peptone dextrose (YPD) medium contained 1% yeast extract,
0.5% peptone, and 2% dextrose, and solid medium included 2% agar. Resting cells were
prepared as in Kebaara et al (Kebaara et al., 2008) with modifications: single colonies
were grown in 25 mL YPD broth at 30°C (unless otherwise noted) for 22-24h to reach
stationary phase, washed three times with 50 mM potassium phosphate buffer (pH6.8),
resuspended in potassium phosphate buffer, and stored at 4°C overnight before use. For
liquid farnesol response assays, resting cells were inoculated at 106 cells/mL in mGPP or
mSPP (2% sucrose replacing glucose) broth with indicated farnesol concentrations. Cells
were then grown at 37ºC, shaking in glass flasks for the indicated times. Trans-trans
farnesol (Sigma, St. Louis, MO) was stored under nitrogen and freshly prepared as a 100
mM stock solution in methanol for each experiment.
Mutant library screen
Mutants were obtained in 96-well plates and plated on mGPP (with 40 µg/ml uridine,
arginine, and histidine added) agar plates containing 0, 10, or 50 µM farnesol. Plates
were incubated at 37°C for 2 days before colony morphology was assessed and compared
to the parental strain, BWP17 for farnesol response.

Wrinkled/hairy colony

morphologies were considered to be composed primarily of filaments and smooth colony
morphologies were considered to be mostly yeast cells. A positive response to farnesol
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was viewed as filamentous colonies without farnesol and smooth colonies in the presence
of farnesol. Farnesol resistant mutants maintained a filamentous morphology, even in the
presence of 50 µM farnesol.
Embedded cell growth
Embedded media were prepared by mixing 104 cells/mL in 30 ml GPP (no GlcNAc
added) or SPP molten agar (cooled to 50°C) with appropriate concentrations of farnesol
and plated. Embedded plates were incubated at 37°C for 12 or 17 hours as indicated.
Only colonies beneath the agar surface were examined.
Microscopy and cell death determination
Cellular morphology during the germ tube assays was determined using a Zeiss Stemi
2000-C light microscope.

Embedded micrographs were taken using a custom MVI

TDM400 tetrad dissecting microscope and Sony Cybershot camera. DIC micrographs
were taken using an Olympus BX51 microscope and a Photometrics CoolSnap HQ CCD
camera. Cell death was determined by methylene blue staining as described by Gibson et
al (Gibson et al., 2009).
DNA analysis and transformation
To create strain AAC2, CKY283 was plated on 5-fluoroorotic acid (5-FOA) containing
media to select for ura- mutants.

AAC2 was subsequently transformed with BsgI-

digested pDB212 to create strain AAC6. Transformations were performed by the lithium
acetate method and transformants were selected on media lacking uridine (Gietz and
Woods, 2002). Newly created strains were confirmed by PCR and Southern blot analysis
(data not shown); restriction digestion and Southern blotting were performed as described
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in the GeneScreen Plus Hybridization Transfer and Detection Protocols (DuPont NEN
Research Products, Boston, MA).
Quantitative real- time PCR
Resting cells were inoculated into 75 mL mGPP broth at 5 x 106 cells/mL, and 0, 50, or
100 µM farnesol was added to each flask. Cells were incubated at 37°C and harvested at
40, 60, or 80 minutes. For harvesting cells, cultures were passed through glass fiber
filters and cells were scraped off the filters to reduce the loss of filamentous cells during
centrifugation. Data shown are from a representative independent experiment performed
in triplicate. Extraction of mRNA was performed with the RiboPure Yeast Kit (Applied
Biosystems, Foster City, CA), and mRNA integrity was assessed by measuring OD260/280
ratios and by examining the appearance on agarose gels. Reverse transcription and PCR
amplification were performed according to manufacturer’s specifications using
MultiScribe Reverse Transcriptase and Power SYBR Green PCR Master Mix (Applied
Biosystems). Real-time PCR reactions were carried out in an ABI Prism 7500 Real-Time
PCR machine (Applied Biosystems).

ACT1 mRNA levels were used as controls.

Primers used to amplify CZF1 and ACT1 and PCR efficiencies were as previously
described (Bassilana et al., 2005).
Farnesol Production Measurements
Extracellular farnesol was extracted from cell-free supernatants of stationary phase
cultures grown in GPP at 30ºC and analyzed by gas chromatography-mass spectrometry,
as described by Hornby et al (Hornby et al., 2001).
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Results
Identification of new genes required for the response to farnesol
To identify important regulators of the farnesol response in C. albicans, a
transposon insertion mutant library of approximately 560 mutants (Supp. Table 1) was
screened for mutants defective in the morphological response to farnesol. The majority
of mutants in this collection are Tn7-UAU1 plasmid insertion mutants (Nobile et al.,
2006); therefore it is desirable to obtain knockout mutants for further characterization due
to the possibility of partial loss-of-function mutations. Mutants that were identified as
farnesol resistant in the original screen were re-streaked on individual plates to rule out
interference from neighboring mutant colonies and to confirm the farnesol resistant
phenotype. Eight mutants were confirmed as farnesol resistant, and they are summarized
in Table 1. Mutants that were unable to interconvert between yeast and filaments (at 30°
and 37°, respectively) were not examined further in this study to rule out mutants that are
merely defective in morphological switching and not the specific response to farnesol.
No mutants were identified that were hypersensitive to farnesol, nor were any detected
that demonstrated growth inhibition in the presence of farnesol.

CZF1 is required for a wild type morphological response to farnesol in both liquid
and embedded conditions
The czf1/czf1 mutant was identified as farnesol-resistant in the mutant library
screen (Table 1) and selected for further characterization based on its known roles in
morphogenesis, white/opaque cell switching, and its connection to the cAMP pathway.
To test the role of Czf1 in the morphological response to farnesol, a double null
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czf1Δ/czf1Δ mutant was compared with its parental strain (CKY101), a wild type clinical
isolate (SC5314), the

heterozygous mutant, and the double null mutant ectopically

expressing CZF1 under the control of the MAL2 promoter in a liquid farnesol response
assay (Fig. 1). In both glucose and sucrose-containing media, SC5314 and CKY101
displayed the expected reduction of early stage filaments (germ tubes) when in the
presence of farnesol. However, the czf1Δ/czf1Δ mutant showed only a minimal reduction
of germ tubes, even in the presence of 100 μM farnesol, and a haploinsufficient farnesol
response phenotype was observed for the heterozygous mutant. Results were similar
whether glucose or sucrose was used as a carbon source. Ectopic complementation of the
czf1Δ/czf1Δ mutant was able to restore the farnesol response similar to that of the
heterozygous mutant in pMAL2-inducing conditions (Fig. 1B; sucrose-containing media),
while there was only a minimal farnesol response in non-inducing conditions, similar to
that of the czf1Δ/czf1Δ mutant (Fig. 1A; glucose-containing media). These results show
that the presence of Czf1 is critical to the ability of C. albicans to respond to farnesol in
liquid media.
Since the first described role for Czf1 was to promote filamentation in embedded
conditions (Brown et al., 1999), we sought to determine whether: 1) C. albicans could
respond to farnesol under such conditions and 2) Czf1 was needed for farnesol response
when embedded in a matrix. For consistency with our prior work studying farnesol
signaling and physiological significance (plates were incubated at 37°C), we utilized
defined GPP or SPP agar plates (lacking GlcNAc, see experimental procedures) in our
embedded assays. Although the growth media and incubation time and temperature used
in this study are different from those initially used by Brown et al (Brown et al., 1999),

99
we still observed a strong filamentation response from C. albicans SC5314 and CKY101
cells in response to growth embedded in a matrix (Fig. 2). When SC5314 and CKY101
cells were grown in embedded media containing 50 μM farnesol, filamentous colonies
were not observed. As with the liquid germ tube formation assays, using glucose versus
sucrose as a carbon source made no difference in filamentation or farnesol response (Fig.
2). This demonstrates the capability of C. albicans to respond to farnesol in an embedded
assay.
As expected, the czf1Δ/czf1Δ mutant exhibited a defective growth pattern in
embedded conditions; filamentation was still observed, but far fewer colonies were
present compared with the wild type and parental strains and colony morphology
appeared different as well (Fig. 2). When the czf1Δ/czf1Δ mutant was grown in agar
containing farnesol, only a moderate farnesol response was observed in that the hyphae
appeared shorter than in untreated samples; however, colonies were still filamentous. As
with the liquid farnesol response assays, the czf1Δ/CZF1 heterozygote maintained a
haploinsufficient phenotype in both farnesol treated and untreated samples: in untreated
samples, the overall level of growth was more similar to that of wild type strains, and in
farnesol-treated samples, colonies were reduced in hyphal formation but still more
filamentous than wild type colonies treated with farnesol.

Ectopic CZF1

complementation of the czf1Δ/czf1Δ mutant produced positive farnesol responses similar
to that of the heterozygote in both GPP and SPP, conditions which should turn off and on,
respectively, the MAL2 promoter (Fig. 2). This suggests unintended leaky promoter
activation in GPP media, possibly resulting in the expression of CZF1 and
complementation of the farnesol response in both GPP and SPP embedded media. These
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results indicate that Czf1 is required for farnesol response in at least two distinct
environmental conditions: liquid, aerobic growth media and embedded in a semi-solid
matrix, new conditions in which to test C. albicans for a morphological farnesol
response.

CZF1 mRNA levels are decreased in the presence of farnesol
Since CZF1 is regulated at the mRNA level, we asked whether CZF1 mRNA
levels are affected by the presence of farnesol. A time-course experiment was performed
to measure CZF1 expression levels in the presence of 0, 50 or 100 μM farnesol, and 40,
60, and 80 minute time points were selected based on previous studies showing the
importance of this time frame to the farnesol response (Kebaara et al., 2008). As with
TUP1 mRNA levels (Kebaara et al., 2008; Mosel et al., 2005), CZF1 levels were most
dramatically affected 60 minutes after treatment with farnesol, showing a greater than 5fold decrease in expression relative to a sample lacking farnesol (Fig. 3B). At all 3 time
points tested, both 50 and 100 μM farnesol reduced CZF1 levels, relative to samples
containing no farnesol (Fig. 3).

These data indicate that CZF1 mRNA levels are

decreased in the presence of farnesol, during time points crucial to the farnesol response.

An efg1Δ/ efg1Δ czf1Δ/ czf1Δ double mutant exhibits decreased farnesol tolerance
that is partially temperature dependent
Upon growth of the efg1Δ/efg1Δ czf1Δ/czf1Δ mutant in liquid media for
preparation of resting cells, an unusual temperature-regulated phenotype was observed.
Mutant cells grown in YPD broth at 30°C appeared small but elongated, reminiscent of
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opaque cells (Fig. 4A), and when the efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant was grown
in YPD broth at 37°C, cells appeared larger and more rounded (Fig. 4B). When these
efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant cells (pre-grown at 30°C) were tested for
farnesol response in the previously described mGPP/mSPP liquid germ tube formation
assays (experimental procedures), we observed what appeared to be cell death. Given the
importance of environmental conditions in the ability of C. albicans to survive and
tolerate farnesol, methylene blue staining was performed during liquid germ tube assays
to more accurately assess the level of cell death occurring in these conditions (Fig. 4C-F).
For the cell death assays, resting cells were prepared as described in experimental
procedures, except that cells were grown at either 30°C or 37°C in YPD broth until
stationary phase was reached. The parental strain CAI4 was used as a control in the 30°C
resting cell group, and as observed for SC5314 in Langford et al (Langford et al., 2010),
no significant cell death was observed in mGPP or in mSPP, even in the presence of 100
μM farnesol. The czf1Δ/czf1Δ and efg1Δ/efg1Δ mutants (Fig. 4C-F) were similarly
resistant to farnesol-mediated killing in the liquid germ tube formation assays. However,
the czf1Δ/czf1Δ mutant could not be tested accurately with methylene blue in these
assays, due to its rapid formation of germ tubes which stain inconsistently with this dye
regardless of the strain used or the presence of farnesol. The arguments for the viability
of the czf1Δ/czf1Δ mutant in the presence of farnesol are twofold:

1) no growth

inhibition was observed in the presence of farnesol on agar plates (data not shown) and 2)
germ tube formation is a process that requires active protein synthesis (Imanishi et al.,
2004) and is unlikely to occur in a dead cell. CAI4 could also not be used as a control at
37°C for similar reasons; cells pre-grown at 37°C start as filaments. On the other hand,
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the efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant and the efg1Δ/efg1Δ czf1Δ/czf1Δ double
mutant ectopically expressing CZF1 (from the 30°C resting cell group) showed extreme
sensitivity to farnesol, regardless of the media used to induce CZF1 expression (Fig 4C,
4E). Conversely, when the efg1Δ/efg1Δ czf1Δ czf1Δ double mutant and the efg1Δ/efg1Δ
czf1Δ/czf1Δ double mutant expressing CZF1 under the control of the MAL2 promoter
from the 37°C resting cell group were tested for farnesol sensitivity, a general decrease in
cell death was observed compared to the 30°C resting cell group (Fig. 4C-F). Based on
these results, Czf1, Efg1, and temperature appear to play important roles in farnesol
tolerance, and both 30°C and 37°C double mutant resting cells were subsequently utilized
for additional experiments in this study.

Ectopically expressing CZF1 in an efg1Δ/ efg1Δ

czf1Δ/czf1Δ

double mutant

partially restores filamentation and farnesol response in liquid and embedded
conditions
Can ectopic expression of CZF1 restore filamentation and response in the efg1Δ/
efg1Δ czf1Δ/czf1Δ double mutant? Liquid germ tube formation assays were performed
on CAI4, efg1Δ/efg1Δ, the efg1Δ efg1Δ czf1Δ/czf1Δ double mutant, and the efg1Δ/efg1Δ
czf1Δ/czf1Δ double mutant ectopically expressing CZF1 under the control of the MAL2
promoter, and only cells that did not stain with methylene blue were counted. For the
30°C resting cell group, only CAI4 was able to produce germ tubes and respond to
farnesol, in both mGPP and mSPP (Fig. 5A, 5C). For the 37°C resting cell group, the
efg1Δ/efg1Δ and the efg1Δ/ efg1Δ czf1Δ/czf1Δ double mutant were capable of producing
very low levels of germ tubes with a slight trend of reduction in the presence of farnesol.
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In conditions which induce CZF1 expression in the efg1Δ/efg1Δ czf1Δ/czf1Δ double
mutant, an increase in germ tube formation was observed when compared to noninducing conditions (Fig. 5B, 5D), and farnesol reduced germ tube formation when CZF1
was expressed.
When CAI4 30°C resting cells were inoculated into the embedded farnesol
response assays, results were similar to SC5314 and CKY101 (Fig. 6). CAI4 produced
filamentous colonies in the absence of farnesol in both GPP and SPP embedded media
and the presence of farnesol resulted in decreased filamentation. Note the smaller hyphae
growing out from the CAI4 colonies treated with farnesol (Fig. 6); because farnesol
delays filamentation rather than block it entirely, the time points selected for observation
are critical. Ideally CAI4 embedded plates should have been checked at 12 h postinoculation for farnesol response (as in Fig. 2) rather than at 17h as shown (no short
filaments are observed in the farnesol-treated CAI4 samples at 12 h, data not shown), but
the 17 h time point was selected in order to be consistent with the other slower-growing
mutant strains being tested in Fig. 6. The efg1Δ/efg1Δ mutant was capable of forming
filamentous colonies under embedded conditions, and a very subtle shortening of
filaments was observed in farnesol-treated samples. An inoculum using 30°C resting
cells for the efg1Δ/efg1Δ mutant is shown in Fig. 6, and similar results were obtained
using an inoculum of 37°C resting efg1Δ/efg1Δ cells. The efg1Δ/efg1Δ czf1Δ/czf1Δ
double mutant was capable of producing filamentous colonies in the absence of farnesol,
regardless of the temperature used during resting cell preparation (Fig. 6).

The

efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant and the efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant
ectopically expressing CZF1 did not produce any colonies in the presence of farnesol
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when 30°C resting cells were used (data not shown), suggesting these cells were killed by
farnesol as they were in the liquid assays. When 37°C resting cells were used for the
efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant, farnesol reduced the number of colonies, but the
colonies that grew were filamentous.

Unexpectedly, the filamentous colonies from

farnesol-treated plates often grew in a different conformation from untreated samples.
The efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant expressing CZF1 under the control of the
MAL2 promoter behaved similarly to the efg1Δ/efg1Δ czf1Δ/ czf1Δ double mutant in noninducing conditions (Fig. 6A), and a subtle increase in colony size and filamentation was
observed in inducing media (Fig. 6B). In the presence of farnesol, these filaments were
slightly shorter. Taken together, both Czf1 and Efg1 are important for farnesol tolerance
in embedded conditions as well, along with temperature. When CZF1 is ectopically
expressed in a strain lacking Czf1 and Efg1, the level of filamentation is partially restored
in both liquid and embedded assays, and farnesol partially suppresses filamentation in
both conditions.

Overproduction of farnesol is not a general quality of farnesol-resistant mutants
Two of the factors known to play a role in the C. albicans morphological farnesol
response, Tup1 and Nrg1, both produced 17 and 19-fold higher levels of farnesol than
wild type and parental strains (Kebaara et al., 2008). In order to determine whether
farnesol overproduction is a general quality of farnesol-resistant mutants, we tested the
farnesol production levels of the czf1Δ/czf1Δ mutant (Fig. 7). Farnesol production levels
were not significantly altered in the czf1Δ/czf1Δ mutant, suggesting a more specific
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involvement of Tup1/Nrg1 in farnesol production that does not require the presence of
Czf1.
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Discussion
In this study, we identified new factors involved in the C. albicans response to
farnesol and have shown that Czf1 in particular plays a prominent role in the
morphological response to farnesol in both liquid aerobic conditions and embedded
conditions; this adds a new function for Czf1 during the quorum sensing response.
Furthermore, CZF1 mRNA levels are decreased in the presence of farnesol at critical
time points during the farnesol response, and unlike another factor involved in farnesol
signaling (Tup1), Czf1 does not appear to regulate farnesol production levels in the cell.
Surprisingly, CZF1, along with EFG1, was also shown to play an important part in
farnesol tolerance; these are the first specific genes identified that control the ability of C.
albicans white a/α cells to survive in the presence of farnesol.
The Ras1-Cyr1-cAMP signaling pathway has been proposed to be the only direct
target for farnesol in C. albicans (Davis-Hanna et al., 2008; Deveau et al., 2010). This
study provides additional evidence supporting a primary role of this pathway in farnesol
signaling. Here we showed that Czf1 is an important factor in the farnesol response. It
has a tight regulatory relationship with Efg1, which is consistent with the Ras1-cAMP
signaling pathway as a central target for farnesol. Further evidence for the significant
role of cAMP signaling during the farnesol response is provided by the identification of
one of the protein kinase A (PKA) isoforms in C. albicans, Tpk1, as farnesol resistant.
The other PKA isoform, Tpk2, was not identified by the farnesol resistance screen as it
was not present in this mutant library collection. A recent study (Deveau et al., 2010)
showed that an additional phenotype of the farnesol response in C. albicans, reactive
oxygen species (ROS) protection, is also mediated by the Ras1-cAMP pathway. The
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Hog1 signaling pathway was shown to participate in ROS protection as well, but through
an unknown connection between the two pathways (Deveau et al., 2010).

Three

additional genes were identified that are potentially important for farnesol resistance:
RLM1, YCK2, and HAP43, also function in different stress responses. These mutants can
possibly be used to fill in some of the gaps between these pathways.
It is intriguing that farnesol can protect the cell from ROS stress, while it can also
kill opaque cells and log-phase, energy-deprived white cells. Since farnesol tolerance in
C. albicans is potentially an active process (Langford et al., 2010), it is of interest to
understand the key components that are involved.

This study provides a new

understanding of farnesol tolerance, by identifying two factors that are required for
survival in the presence of farnesol: Czf1 and Efg1.

We speculate that it is no

coincidence that both of these factors also play critical roles in white/opaque cell
switching (Ramirez-Zavala et al., 2008; Sonneborn et al., 1999; Srikantha et al., 2000;
Vinces and Kumamoto, 2007; Zordan et al., 2007) since opaque cells are inherently more
sensitive to farnesol killing than are white cells (Dumitru et al., 2007). Farnesol killed
efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant cells in liquid aerobic conditions, and it appeared
to do the same in embedded media due to the lack of growth when using 30°C resting cell
inocula. It is unclear why single efg1Δ/efg1Δ and czf1Δ/czf1Δ mutants are resistant to
farnesol killing, while the double mutant is overly sensitive. Czf1 and Efg1 have a
synthetic effect on farnesol resistance, as farnesol tolerance was only observed in the
single mutants and not the double mutant.

The mere presence of CZF1 in the

efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant (via expression of CZF1 by the MAL2 promoter)
was not sufficient, however, to provide protection from farnesol induced cell death,
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suggesting CZF1 may act upstream of EFG1 in this example. It is also possible that the
presence of Czf1’s native promoter is required for proper regulation in response to this
particular stimulus when Efg1 is absent. Another intriguing question raised by this study
is the role of temperature in farnesol tolerance. Why was the efg1Δ/efg1Δ czf1Δ/czf1Δ
double mutant more tolerant of farnesol when grown at 37°C? The answer may be tied to
indirect farnesol production measurements suggesting that C. albicans produces slightly
higher levels of farnesol at higher temperatures (Hornby et al., 2001). Further, there is
likely some additional factor(s) that plays a minor role in farnesol tolerance and is
regulated by shifts in temperature. Wor1/2 are potential candidates for such a role, in
part due to their regulation of white/opaque switching (Huang et al., 2006; Zordan et al.,
2006; Zordan et al., 2007).
While Czf1 was shown to be part of a farnesol-resistance mechanism in C.
albicans, it also strongly contributes to the morphological response to farnesol. In cells
lacking Czf1 (czf1Δ/czf1Δ mutants), farnesol was unable to suppress filamentation, and
ectopic complementation of CZF1 in these cells restored the ability of farnesol to block
germ tube formation in both liquid and embedded environmental conditions.
Furthermore, in efg1Δ/efg1Δ czf1Δ/czf1Δ double mutants, CZF1 ectopic expression was
able to partially restore filamentation and the morphological response to farnesol. These
results are consistent with Czf1 functioning downstream of Efg1 during the
morphological farnesol response. Through the course of testing farnesol response in
conditions which either turn on or off the MAL2 promoter, we have shown that the use of
glucose versus sucrose as a carbon source had no distinguishable effect on the ability of
the cells to respond to farnesol.
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The many effects of farnesol on C. albicans appear to be relatively unique to the
fungus, compared with other bacterial species and fungal genera [reviewed by Langford
et al (Langford et al., 2009)]. The finding that Czf1 plays a central role in the unique
morphological and tolerance responses in C. albicans is consistent with the observation
that Saccharomyces cerevisiae (which does not respond to farnesol) and other closely
related ascomycetes lack a Czf1 homolog (Vinces et al., 2006) while other Candida
species contain CZF1 homologs.

As an example, the CZF1 gene in Candida

dubliniensis, a Candida species that produces the second highest farnesol levels, is
farnesol tolerant, and morphologically responds to farnesol (Henriques et al., 2007;
Weber et al., 2008) has the highest homology to the C. albicans CZF1 gene with 81%
identity at the nucleotide level (data not shown). Furthermore, the unusually large 5’
upstream region of CZF1, the CZF1 gene itself, and neighboring genes at the CZF1 locus
(Vinces et al., 2006) appear to be conserved to varying degrees in additional Candida
species whose sequence information has been recently made available including:
Candida tropicalis, Lodderomyces

elongisporius, Candida lusitaniae, and Candida

guillermondii (data not shown).
In conclusion, we have identified new roles for Czf1 in mediating the C. albicans
tolerance to farnesol as well as farnesol-mediated filament inhibition.

While the

connection of Czf1 to other factors known to play a role in the C. albicans farnesol
response, such as the cAMP pathway, is apparent, others links remain unclear. For
example, cross-regulation among many of the farnesol response pathways was recently
summarized (Deveau et al., 2010), but little is known about the regulation of Tup1/Nrg1
and how these factors fit into the farnesol signaling network. Furthermore, other proteins
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involved in Ras1-Cyr1-cAMP signaling such as Ras2, Cap1, and G-actin (Hall and
Muhlschlegel, 2009; Zhu et al., 2009; Zou et al., 2009) have not been tested for possible
roles in farnesol signaling and may yet prove to be involved. This points to the fact that
farnesol can be an extremely useful tool for studying signal transduction in C. albicans
by demonstrating the presence of new connections between signaling pathways.
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Figure Legends
Figure 4-1.

Czf1 is required for the morphological response to farnesol in liquid

conditions. C. albicans resting cells were inoculated into glass flasks at 106 cells/mL in
either mGPP (A) or mSPP (B) broth, and 0, 50, or 100 μM farnesol was added. Cultures
were incubated for 1 h at 37°C with shaking at 225 rpm and percentage of germ tube
formation was subsequently determined (czf1Δ/ czf1Δ = CKY230, czf1Δ/CZF1=
CKY116, czf1Δ/ czf1Δ pMAL2-CZF1 = CKY231). Data shown are from independent
experiments performed in triplicate; these were repeated with similar results on at least
two separate occasions.
Figure 4-2. Czf1 is required for the morphological response to farnesol in embedded
media. C. albicans resting cells were mixed with either GPP (A) or SPP (B) molten agar
and 0 or 50 μM farnesol as described in experimental procedures, and incubated at 37°C
for 12 h. Independent experiments were repeated in duplicate with similar results.
Figure 4-3. CZF1 mRNA expression is decreased in the presence of farnesol.

SC5314

resting cells were inoculated into mGPP broth for 40, 60, or 80 minutes (A-C,
respectively) with 0, 50, or 100 μM farnesol and subsequently harvested for RNA
extraction. Quantitative real-time PCR was used to measure relative CZF1 mRNA levels
with ACT1 used as a reference gene. CZF1 levels in the minus farnesol samples were set
at zero and fold change in CZF1 levels for samples with farnesol added are shown. Data
are averages from three replicates.
Figure 4-4. Czf1, Efg1, and temperature play a role in farnesol tolerance. The czf1Δ/
czf1Δ efg1Δ/ efg1Δ double mutant was grown in YPD broth at 30°C (A) or 37°C (B) for
24 h and differences cell morphology was observed. Scale bar = 10 μm. Cells were
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grown at either 30°C or 37°C in YPD broth until stationary phase was reached (24 h,
except 48 h for CAI4 and efg1Δ/ efg1Δ strains) to prepare resting cells as described in
experimental procedures. 106 cells/mL of these resting cells were inoculated into mGPP
(C,D) or mSPP (E,F) broth and 0, 50, or 100 μM farnesol was added. Cultures were
incubated at 37°C with shaking at 225 rpm, and cell death by methylene blue staining
was determined after 90 min (efg1Δ/ efg1Δ = HLC67; czf1Δ/czf1Δ efg1Δ/efg1Δ =
CKY283; czf1Δ/czf1Δ efg1Δ/efg1Δ pMAL2-CZF1 = AAC6).

Data shown are from

independent experiments performed in triplicate; these were repeated with similar results
on at least two separate occasions.
Figure 4-5. Ectopic expression of CZF1 in a czf1Δ/czf1Δ efg1Δ/efg1Δ double mutant
partially restores filamentation and farnesol response in liquid conditions. Cells were
grown at either 30°C or 37°C until stationary phase was reached to prepare resting cells.
106 cells/mL of these resting cells were inoculated into mGPP (A,B) or mSPP (C,D)
broth and 0, 50, or 100 μM farnesol was added. Cultures were incubated at 37°C with
shaking at 225 rpm, and percentage of germ tube formation was subsequently
determined. Data shown are from independent experiments performed in triplicate; these
were repeated with similar results on at least two separate occasions.
Figure 4-6. Czf1 and Efg1 are both required for a wild type morphological response and
tolerance to farnesol in embedded agar. C. albicans resting cells (prepared at 30°C or
37°C) were mixed with either GPP (A) or SPP (B) molten agar and 0 or 50 μM farnesol
as described in experimental procedures, and incubated at 37°C for 17 h. Colonies in
figure were from 30°C resting cells unless otherwise noted. Independent experiments
were repeated in duplicate with similar results.
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Figure 4-7. A czf1Δ/czf1Δ mutant produces farnesol levels similar to that of wild type
and parental strains. Cells were grown in GPP broth at 30°C for 48 hours prior to
farnesol extraction and quantification, as described in methods.
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A.
Liquid Farnesol Response Assay; mGPP
100

% germ tube formation

80

60

0 FOH
50 μM FOH
100 μM FOH

40

20

0
SC5314

CKY101

czf1Δ/czf1Δ

czf1Δ/CZF1

czf1Δ/czf1Δ
pMAL2-CZF1

B.
Liquid Farnesol Response Assay; mSPP
100

% germ tube formation

80

60

0 FOH
50 μM FOH
100 μM FOH

40

20

0
SC5314

CKY101

czf1Δ/czf1Δ czf1Δ/CZF1 czf1Δ/czf1Δ
pMAL2-CZF1

123
Figure 4-2
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Figure 4-4
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Figure 4-4
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Figure 4-5
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Figure 4-6
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Table 4-1. Summary of insertion mutants with an impaired farnesol response.
Mutant
czf1/czf1

S. cerevisiae
ortholog
None

tpk1/tpk1

Tpk2

rlm1/rlm1

Rlm1

stp2/stp2

Stp2

hof1/hof1
yck2/yck2

Hof1
Yck2

zcf14/zcf14
hap43/hap43

Hap1
Yap3

Predicted or known biological processes
Zinc finger transcription factor for filamentation
under embedded conditions and positive regulator of
white to opaque switching; binds Efg1 and expression
controlled by Efg1 and Czf1 (Brown et al., 1999;
Hornby et al., 2001; Ramirez-Zavala et al., 2008;
Vinces et al., 2006; Vinces and Kumamoto, 2007;
Zordan et al., 2007)
Catalytic subunit of cAMP-dependent protein kinase
A, regulator of morphogenesis; Tpk2 isoform;
involved in multiple stress responses (Bockmuhl et
al., 2001; Cloutier et al., 2003; Giacometti et al.,
2009; Maidan et al., 2005)
Transcription factor for genes involved in cell wall
organization and biogenesis and various stress
responses (Bruno et al., 2006; Sampaio et al., 2009)
Transcription factor for amino acid permease genes
(Martinez and Ljungdahl, 2005)
Role in cytokinesis (Li et al., 2006)
Maintenance of cell polarity, antimicrobial peptide
resistance, contributes to epithelial cell damage (Park
et al., 2009)
Putative transcription factor
Transcription factor, involved in iron limitation
response (Baek et al., 2008)
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Table 4-2. Candida albicans strains and plasmids used in this study.
Parental
strain

Genotype/Description

Source

Clinical isolate

CAF2

Clinical
isolate
CAI-4

CAI-4

CAF2

ura3::imm434/ura3::imm434

BWP17

RM1000

HLC67
(efg1Δ/ efg1Δ)
CKY101

CAI-4

CKY230
(czf1Δ/ czf1Δ)

CAI-4

CKY116
(czf1Δ/CZF1)
CKY231
(czf1Δ/ czf1Δ
pMAL2-CZF1)
CKY283
(czf1Δ/ czf1Δ
efg1Δ/ efg1Δ)
AAC2

CAI-4

ura3::imm434/ura3::imm434
arg4::hisG/arg4::hisG
his1::hisG/his1::hisG
ura3::imm434/ura3::imm434
efg1::hisG/efg1::hisG
ura3::imm434/ura3::imm434
ade2::pDB152
ura3::imm434/ura3::imm434
czf1::hisG/czf1::hisG
ade2::pMAL2-URA3
ura3::imm434/ura3::imm434
CZF1/czf1::hisG -URA3-hisG
ura3::imm434/ura3::imm434
czf1::hisG/czf1::hisG
ade2::pMAL2-CZF1-URA3
ura3::imm434/ura3::imm434
czf1::hisG/czf1::hisG-URA3hisG efg1::hisG/efg1::hisG
ura3::imm434/ura3::imm434
czf1::hisG/czf1::hisG
efg1::hisG/efg1::hisG
ura3::imm434/ura3::imm434
czf1::hisG/czf1::hisG
efg1::hisG/efg1::hisG
ade2::pMAL2-CZF1-URA3

Alexander Johnson
(Gillum et al., 1984)
Alexander Johnson
(Leberer et al., 2001)
Alexander Johnson
(Fonzi and Irwin, 1993)
Aaron Mitchell (Nobile
and Mitchell, 2005)

C. albicans
strains
SC5314

CAI-4

CAI-4
CAI-4
CKY283

AAC6
AAC2
(czf1Δ/ czf1Δ
efg1Δ/ efg1Δ
pMAL2-CZF1)
Plasmids
pDB212

Ura+ derivative of CAI-4

pMAL2-CZF1 URA3 ade2’
Ampr

Gerald Fink (Lo et al.,
1997)
Carol Kumamoto
(Brown et al., 1999)
Carol Kumamoto
(Vinces et al., 2006)
Carol Kumamoto
Carol Kumamoto
(Brown et al., 1999)
Carol Kumamoto
(Giusani et al., 2002)
This study
This study

Carol Kumamoto
(Brown et al., 1999)
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Supplementary Table 4-1. List of mutants screened in this study.
Mutant ORF#
orf19.1795
orf19.7291
orf19.6760
orf19.4669
orf19.5037
orf19.11450
orf19.9364
orf19.6970
orf19.10248
orf19.9791
orf19.6952
orf19.9364
orf19.4966
orf19.7479
orf19.7412
orf19.5328
orf19.1857
orf19.8907
orf19.14178
orf19.4746
orf19.5235
orf19.3995
orf19.8635
orf19.3171
orf19.2723
orf19.768
orf19.3208
orf19.1409
orf19.564
orf19.856
orf19.11598
orf19.4284
orf19.4369
orf19.7389
orf19.4668
orf19.9508
orf19.5011
orf19.4658

133
orf19.1509
orf19.1593
orf19.695
orf19.6036
orf19.3014
orf19.3701
orf19.4763
orf19.5495
orf19.1805
orf19.13950
orf19.12265
orf19.5571
orf19.7614
orf19.10359
orf19.2990
orf19.4257
orf19.2237
orf19.771
orf19.6729
orf19.3396
orf19.2237
orf19.3563
orf19.2033
orf19.11973
orf19.3171
orf19.769
orf19.5251
orf19.7381
orf19.3202
orf19.1825
orf19.5571
orf19.580
orf19.3764
orf19.9081
orf19.5365
orf19.3012
orf19.12351
orf19.5445
orf19.6261
orf19.3009
orf19.10169

134
orf19.2763
orf19.2392
orf19.4893
orf19.2348
orf19.2653
orf19.5292
orf19.4457
orf19.6194
orf19.5094
orf19.271
orf19.1759
orf19.12603
orf19.6032
orf19.7201
orf19.9115
orf19.1005
orf19.4369
orf19.7389
orf19.4519
orf19.2660
orf19.4529
orf19.7472
orf19.6344
orf19.4428
orf19.1614
orf19.4369
orf19.3818
orf19.8837
orf19.11598
orf19.3906
orf19.7016
orf19.7400
orf19.9331
orf19.6185
orf19.3678
orf19.4535
orf19.7194
orf19.5001
orf19.4244
orf19.658
orf19.8326

135
orf19.3530
orf19.6194
orf19.6100
orf19.1510
orf19.4214
orf19.4285
orf19.3125
orf19.7208
orf19.5866
orf19.2938
orf19.9115
orf19.12706
orf19.6850
orf19.1252
orf19.5352
orf19.7451
orf19.7401
orf19.271
orf19.1394
orf19.2901
orf19.6737
orf19.811
orf19.2808
orf19.769
orf19.7207
orf19.530
orf19.4979
orf19.7381
orf19.7400
orf19.6950
orf19.14148
orf19.4409
orf19.4872
orf19.4513
orf19.6971
orf19.2270
orf19.3190
orf19.7410
orf19.4440
orf19.13704
orf19.6365

136
orf19.4116
orf19.3678
orf19.7381
orf19.3844
orf19.1331
orf19.1276
orf19.5761
orf19.7576
orf19.813
orf19.1907
orf19.4846
orf19.4543
orf19.4518
orf19.4823
orf19.7447
orf19.7324
orf19.2350
orf19.10841
orf19.5664
orf19.7610
orf19.248
orf19.425
orf19.4243
orf19.1628
orf19.3707
orf19.829
orf19.3254
orf19.1291
orf19.6365
orf19.4969
orf19.2061
orf19.1793
orf19.3122
orf19.5887
orf19.4188
orf19.4139
orf19.1795
orf19.5100
orf19.6267
orf19.7583
orf19.11659

137
orf19.7451
orf19.4474
orf19.3012
orf19.6036
orf19.4743
orf19.6763
orf19.4010
orf19.7207
orf19.2508
orf19.5016
orf19.5023
orf19.998
orf19.7355
orf19.814
orf19.411
19.6817
19.3809
19.7247
19.11410
19.4433
19.5908
19.7150
19.12215
19.12786
19.4972
19.173
19.4125
19.4766
19.3187
19.3986
19.6680
19.5026
19.4670
19.4318
19.7359
19.723
19.7518
19.2745
19.7583
19.5729
19.7570

138
19.3127
19.4568
19.1135
19.1187
19.5548
19.3308
19.2647
19.6182
19.431
19.7318
19.5380
19.1497
19.1255
19.3305
19.4573
19.9191
19.1007
19.2280
19.5338
19.4767
19.4776
19.4778
19.13396
19.2356
19.9326
19.909
19.2054
19.2260
19.798
19.889
19.2331
19.2315
19.1178
19.2393
19.2399
19.2458
19.3088
19.2612
19.2674
19.1358
19.1496

139
19.3193
19.3300
19.1589
19.1565
19.3405
19.3407
19.1694
19.1729
19.1826
19.3683
19.3753
19.3835
19.6781
19.6845
19.6850
19.7025
19.10266
19.10478
19.1227
19.1822
19.2064
19.2077
19.2432
19.2623
19.3390
19.4649
19.487
19.567
19.6985
19.718
19.735
19.976
orf19.3966
orf19.3966
orf19.299
orf19.299
orf19.4887
orf19.4887
orf19.2623
orf19.2623
orf19.1563

140
orf19.1563
orf19.1563
orf19.3010.1
orf19.3010.1
orf19.3010.1
orf19.4884
orf19.4884
orf19.3434
orf19.3434
orf19.2613
orf19.2613
orf19.2613
orf19.5412
orf19.4981
orf19.4981
orf19.4981
orf19.1277
orf19.1277
orf19.5867
orf19.5867
orf19.3869
orf19.3869
orf19.3869
orf19.1490
orf19.1490
orf19.1490
orf19.2476
orf19.2476
orf19.2476
orf19.5674
orf19.893
orf19.532
orf19.532
orf19.1714
orf19.3642
orf19.7251
orf19.3193
orf19.7374
orf19.166
orf19.2647
orf19.3188

141
orf19.1358
orf19.1499
orf19.6817
orf19.681
orf19.4662
orf19.5848
orf19.6407
orf19.5975
orf19.1032
orf19.2356
orf19.6985
orf19.7371
orf19.4766
orf19.3012
orf19.5133
orf19.5917
orf19.6203
orf19.861
orf19.6038
orf19.5849
orf19.4649
orf19.3294
orf19.2623
orf19.2315
orf19.1069
orf19.3190
orf19.6102
orf19.723
orf19.2540
orf19.3434
orf19.4961
orf19.5953
orf19.6124
orf19.173
orf19.6121
orf19.217
orf19.1035
orf19.1718
orf19.2423
orf19.255
orf19.2748

142
orf19.2753
orf19.2808
orf19.3252
orf19.3405
orf19.3876
orf19.4145
orf19.4166
orf19.4225
orf19.4288
orf19.4450
orf19.4524
orf19.5924
orf19.5940
orf19.7372
orf19.6227
orf19.6713
orf19.7319
orf19.5995
orf19.5759
orf19.4979
orf19.2395
orf19.6626
orf19.7523
orf19.1813
orf19.2217
orf19.702
orf19.7388
orf19.7388
orf19.896
orf19.896
orf19.7001
orf19.7001
orf19.4866
orf19.4866
orf19.5181
orf19.5181
orf19.4252
orf19.4252
orf19.4084
orf19.4084
orf19.469

143
orf19.469
orf19.5350
orf19.5350
orf19.2605
orf19.2605
orf19.5224
orf19.5224
orf19.663
orf19.663
orf19.451
orf19.451
orf19.1874
orf19.1874
orf19.4242
orf19.4242
orf19.2395
orf19.2395
orf19.3047
orf19.3047
orf19.794
orf19.794
orf19.4892
orf19.4892
orf19.5408
orf19.5408
orf19.223
orf19.223
orf19.3256
orf19.3256
orf19.1196
orf19.1196
orf19.835
orf19.835
orf19.469
orf19.469
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CHAPTER 5
Summary and Future Directions
With a brief excerpt from:
Langford, M.L., Atkin, A.L., and Nickerson, K.W. (2009) Cellular Interactions of
Farnesol, a Quorum Sensing Molecule Produced by Candida albicans. Future Microbiol.
4: 1353-62.
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Summary
Farnesol has effects on all eukaryotic cells tested, and for many cell types, a low
level of farnesol is sufficient to inhibit growth or induce cell death. In contrast, C.
albicans has evolved mechanisms to produce and tolerate higher levels of farnesol and
use it as a quorum sensing molecule. A current challenge is to develop a unifying model
for the mode of action for farnesol in eukaryotes and elucidate the mechanisms used by
C. albicans to evade the adverse effects of farnesol and respond to farnesol as a signaling
molecule. In this study, we established environmental conditions in which C. albicans is
able to resist farnesol-mediated cell death: stationary phase cells provided with an energy
source. Conversely, we have defined conditions that stimulate sensitivity to farnesol in
C. albicans: energy-deprived, log phase cells (Chapter 2). Using the aforementioned
environmental conditions that allow C. albicans to tolerate farnesol and use it as a
signaling molecule, two novel factors were identified that are involved in the
morphological response to farnesol: Tup1 and Czf1 (Chapters 3, 4). It seems that
farnesol suppression of filamentation during C. albicans quorum sensing works through
both positive and negative regulators of filamentation (Czf1 and Tup1, respectively) to
achieve the resulting change in morphology. Czf1 also played a dual role in the farnesol
response, as it was partially responsible for farnesol tolerance in quorum sensing
conditions.

Farnesol Tolerance and Sensitivity in C. albicans
The precise mechanism for C. albicans white cell farnesol tolerance during
quorum sensing remains unclear. Since the effects of farnesol on other organisms have
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been studied in seventeen different species (summarized in Chapter 1), this is an
important mechanism to understand in the field of interspecies communication.
Furthermore, as exogenous farnesol has many effects in the mammalian host during
infection such as preventing infection of mucosal surfaces, increasing virulence in a
disseminated infection and interference of the host cytokine response [Chapter 1 and
(Navarathna et al., 2007)], understanding the farnesol tolerance mechanism in C.
albicans may prove useful therapeutically.
It is unknown how C. albicans white cells are resistant to the toxic effects of
farnesol. Do the cells have a type of passive resistance, such as changes in membrane
composition, or do they undergo active resistance, such as conversion of farnesol into a
non-toxic compound? In order to look for genes that may be involved in farnesol
tolerance, a screening approach was used (Chapter 4).

However, the screen was

unsuccessful in identifying mutants that were growth-inhibited (sensitive) in the presence
of farnesol, even at levels as low as 10 µM. Even so, the mutant library collection used
in this study is by no means a complete representation of the entire collection of C.
albicans predicted open reading frames (ORFs); there are 6197 predicted ORFs in the
genome, compared with the 560 mutants contained within the mutant library collection
used, leaving plenty of room for future identification of farnesol tolerance factors as more
mutants become available.
The identification of Czf1 and Efg1 as important players in farnesol survival is
intriguing because a farnesol-sensitive phenotype was observed only when both genes
were deleted. Ectopic expression of CZF1 in the efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant
could not provide complete protection from farnesol killing yet the single efg1Δ/efg1Δ
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and czf1Δ/czf1Δ mutants were unharmed (Chapter 4). Perhaps Czf1 functions upstream
of Efg1 in this situation, or the normal regulation of CZF1 might be especially important
in the absence of EFG1. In the reverse situation, could ectopic expression of EFG1 in the
double mutant restore partial or full farnesol resistance? Czf1 and Efg1 likely regulate a
redundant gene or set of genes for farnesol tolerance because the single mutants do not
show a farnesol sensitive phenotype while the double mutant exhibits a synthetic farnesol
sensitivity phenotype. While changes in gene expression have been extensively studied
in the efg1Δ/efg1Δ mutant compared to wild type/parental strains (Braun and Johnson,
2000; Harcus et al., 2004; Sohn et al., 2003), there is no matching data for Czf1
available. Microarray analyses designed to complement existing data on Efg1 may reveal
genes that are commonly regulated by Czf1 and Efg1, either directly or indirectly. Genes
whose expression was altered in cells lacking Czf1 and Efg1 could also be compared to
existing microarray data comparing gene expression between white and opaque cells
(Lan et al., 2002; Tsong et al., 2003; Zhao et al., 2005). Genes that are differentially
expressed in opaque cells, efg1Δ/efg1Δ, and czf1Δ/czf1Δ mutants would comprise a list of
strong candidates for potential farnesol resistance factors. One further step that may be
taken would be to look at other farnesol-sensitive organisms to see if homologs to the
candidate farnesol resistance genes are present in those species.
The role of temperature in farnesol tolerance (the efg1Δ/efg1Δ czf1Δ/czf1Δ double
mutant was more sensitive at 30°C than at 37°C) may be correlated to evidence
suggestive of slightly elevated farnesol production levels at higher temperatures (Hornby
et al., 2001). It would be informative to examine changes in gene expression and to
measure farnesol production in the efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant at both 30°C
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and 37°C, compared to wild type and parental strains. Differentially regulated genes may
be partly responsible for the cellular morphology and farnesol resistance changes
observed at these two temperatures. One would also predict that farnesol production may
be significantly lowered at 30°C based on the degree of farnesol sensitivity for the double
mutant cells grown at this temperature. Analysis of the efg1Δ/efg1Δ single mutant would
need to be included in this study; initial results using this mutant resulted in high
variation between replicates (M.L. Langford, data not shown) and further replicates will
need to be conducted to determine whether Efg1 plays a role in farnesol production.
Furthermore, a possible role for Tup1 in farnesol resistance should not be ignored. As
tup1Δ/tup1Δ mutants produced 17-fold more farnesol compared to wild type and parental
strains, these cells may have heightened abilities to tolerate farnesol. However, it will be
difficult to study higher tolerance to farnesol in these mutant cells since they are locked
in the filamentous morphology (unless secondary mutations are introduced), unlike the
efg1Δ/efg1Δ and czf1Δ/czf1Δ mutants. Preliminary experiments must first be conducted
to better understand the tup1Δ/tup1Δ farnesol resistance, such as a comparison of farnesol
tolerance between yeast, pseudohyphal, and hyphal cells. If the loss of Tup1 results in
higher farnesol tolerance, would a triple efg1Δ/czf1Δ/tup1Δ mutant have restored
resistance? What would the farnesol production levels in that mutant be? It is intriguing
that all three of these factors play a prominent role in white-opaque switching, farnesol
production and/or farnesol tolerance, as well as the morphological response to farnesol.
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Signaling During the Morphological Response to Farnesol in C. albicans
Because the presence of a single farnesol receptor has still not been identified, it
remains a possibility that there may be multiple targets for farnesol in the cell. Two
models (network and central processor) have been proposed with regard to C. albicans
signaling in general (Braun and Johnson, 2000) and are worth considering when
examining the farnesol response. That study suggested C. albicans follows the network
signaling model, whereby many individual connections are formed between the different
regulatory pathways in the cell. This conclusion was reached when they observed that
several hyphal-specific genes are not regulated in unison in different hyphal inducing
conditions but in fact respond as individuals. If network signaling is indeed occurring
during the farnesol response, farnesol could help identify many of the different branches
in these pathways.
The Ras1-cAMP pathway has been identified as a critical, even a possible direct
target for farnesol inhibition during yeast to filament inhibition by farnesol (Davis-Hanna
et al., 2008; Deveau et al., 2010). Although a recent study (Davis-Hanna et al., 2008)
showed the inability of the ras1Δ/ras1Δ mutant to respond to farnesol in aerobic
conditions, it remains undetermined if it is capable of responding to farnesol under
different environmental conditions, specifically during embedded growth.

The

ras1Δ/ras1Δ mutant is defective in filamentation under aerobic conditions and embedded
in YPS (yeast extract, peptone, sucrose) agar (Maidan et al., 2005), but it has not been
tested in our GPP embedded media. If filamentation can be achieved in our embedded
assay, the morphological response to farnesol can be tested; this would both complement
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the existing aerobic data and determine the importance of Ras1 to the farnesol response in
other environmental conditions.
A recently characterized protein, Ras2 (Zhu et al., 2009), plays an antagonistic
role with Ras1 regarding stationary phase entry, stress resistance, and cellular cAMP
levels. Although Ras2 shares poor sequence homology with Ras1 and phylogenetic
analyses have suggested it belongs to a divergent group of fungal Ras proteins (Ras2 has
a homolog with high sequence similarity to C. dubliniensis), it still has functional
GTPase activity (Zhu et al., 2009). More importantly, since Ras2 has an antagonistic
effect on many of the physiological roles of Ras1, it may somehow be involved in
farnesol signaling as well.

The ras2Δ/ras2Δ mutant maintains the ability to make

filaments in aerobic and embedded conditions, making it an ideal candidate for testing the
morphological response to farnesol. Might Ras2 play an antagonistic response to Ras1
during farnesol signaling as well?
While one new factor involved in the morphological response to farnesol, Czf1,
has a known connection to the Ras1-cAMP pathway in C. albicans, it remains unknown
how another factor involved, Tup1, fits into this model (Chapters 3, 4). Further studies
using farnesol as a tool may decipher whether Tup1 is somehow connected to the cAMP
pathway or is independently involved in the farnesol response. Construction of a triple
efg1Δ/czf1Δ/tup1Δ mutant may prove useful, not only to study farnesol tolerance as
mentioned earlier, but to study farnesol signaling as well. If this mutant is viable, what
would its morphology be in different growth conditions? Would this mutant be capable
of responding to farnesol? Vectors that can be used to delete EFG1, CZF1, and TUP1
have already been constructed, as well as ectopic expression constructs for all three genes
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(Bockmuhl and Ernst, 2001; Braun and Johnson, 1997; Brown et al., 1999; Lo et al.,
1997), a couple of which have already been obtained by the Atkin laboratory. Therefore,
all the necessary tools are available to create not only a triple mutant, but the remaining
double mutant combinations (i.e. tup1Δ/czf1Δ, efg1Δ/tup1Δ) and ectopically express each
gene in the desired mutant strains. Construction and analysis of these strains can provide
valuable insight into C. albicans morphological signaling networks. For example, if
TUP1 was ectopically expressed in the efg1Δ/efg1Δ czf1Δ/czf1Δ double mutant
background and no differences in farnesol response were observed, Tup1 would most
likely be acting upstream of these two factors.
Other ways to test for a possible connection between Tup1 and the Ras1-cAMP
pathway would be to determine whether Czf1 and/or Efg1 are responsible for the increase
in TUP1 mRNA levels and/or Tup1 protein levels observed during the morphological
response to farnesol. For example, are the TUP1 mRNA levels in a czf1Δ/czf1Δ mutant
background still increased during farnesol treatment? If the mRNA levels do not increase
in response to farnesol, it would suggest that Czf1 is either directly or indirectly
responsible for the regulation of Tup1 during the farnesol response, and this information
could potentially provide the first data regarding the regulation of Tup1 since regulatory
factors upstream of Tup1 remain unknown.
Regardless of whether Czf1 would specifically regulate TUP1 expression, followup experiments designed to better understand which genes are controlled by Czf1 are
desirable for the C. albicans research field. While it has been shown to bind its own
promoter and negatively regulate its expression, it is unknown what other genes are
directly regulated by Czf1. Moreover, because it controls so many processes in C.
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albicans:

morphogenesis, white-opaque switching, farnesol tolerance, and the

morphological response to farnesol, it is of considerable interest to identify genes that are
directly regulated by this unique transcription factor, both without and in the presence of
farnesol. ChIP (chromatin immunoprecipitation)-Seq, would be an ideal procedure to
determine direct targets of Czf1. Prior to this experiment, however, Czf1 antibodies
would ideally be raised (all protein work concerning Czf1 has utilized an HA-tagged
Czf1 protein, which would have the potential to slightly alter the natural function of the
protein).

The ChIP-Seq method would first cross-link DNA (chromatin)-protein

complexes and shear the DNA into smaller pieces. An antibody against Czf1 can be used
to immunoprecipitate DNA bound with Czf1, and deep sequencing could subsequently be
used to sequence the precipitated DNA. Sequence analyses would finally provide the
location of the Czf1 binding sites in the C. albicans genome.
In addition to CZF1, the mutant screen from Chapter 4 identified 7 other genes
that may play a role in the farnesol response. Of note, identification of STP2 was a bit of
a surprise, as it is the only gene identified with no direct ties to morphogenesis or stress
responses. Either the acquisition of amino acids plays a more important role during
farnesol signaling than is currently appreciated, or Stp2 may participate in farnesol
signaling in an undiscovered manner. The RLM1 and YCK2 genes are both attractive
candidates for further analysis, particularly when examining the farnesol survival
mechanism, due to their known roles in stress resistance.
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Final Thoughts
One common theme that can be discerned from studying the farnesol response in
C. albicans is that farnesol affects a variety of regulatory factors within the polymorphic
fungus. This unique feature has allowed us to study the interrelatedness of some of the
signaling networks in an effort to better understand the genetic pathways present in the
opportunistic pathogen. Farnesol can be used as an instrument to dissect the complicated
and intertwined pathways present in C. albicans, including pathways yet to be fully
understood, such as the regulation of Tup1, Hog1 signaling, and stress response
signaling. Although farnesol was initially discovered as a quorum sensing molecule that
only regulates morphogenesis, the discovery of its many other functions will hopefully
allow for a more complete understanding of C. albicans signaling as a whole.
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